Determine 10-K 27 Jun 14 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Mar. 31, 2014	Jun. 19, 2014	Sep. 30, 2013
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'SELECTICA INC	'	'
Document Type	'10-K	'	'
Current Fiscal Year End Date	'--03-31	'	'
Entity Common Stock, Shares Outstanding	'	5,474,067	'
Entity Public Float	'	'	$12,078,705
Amendment Flag	'false	'	'
Entity Central Index Key	'0001090908	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Document Period End Date	31-Mar-14	'	'
Document Fiscal Year Focus	'2014	'	'
Document Fiscal Period Focus	'FY	'	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified
Current assets	'	'
Cash and cash equivalents	$16,907	$12,098
Accounts receivable, net of allowance for doubtful accounts of $247 and $111 as of March 31, 2014 and 2013, respectively	3,006	3,455
Prepaid expenses and other current assets	689	853
Total current assets	20,602	16,406
Property and equipment, net	312	407
Capitalized software	856	'
Other assets	30	39
Total assets	21,800	16,852
Current liabilities	'	'
Credit facility	6,949	6,000
Accounts payable	1,371	1,010
Accrued payroll and related liabilities	648	982
Accrued restructuring costs	'	232
Other accrued liabilities	345	163
Deferred revenue	5,131	6,153
Total current liabilities	14,444	14,540
Long-term deferred revenue	618	1,772
Other long-term liabilities	'	20
Total liabilities	15,062	16,332
Stockholder's Equity:	'	'
Total stockholders' equity	3,085	520
Series D Preferred Stock [Member]	'	'
Current liabilities	'	'
Series D redeemable convertible preferred stock, $.0001 par value, designated, issued and outstanding shares: 680,047 shares at March 31, 2014	3,653	'
Stockholder's Equity:	'	'
Common stock, $0.0001 par value: Authorized: 15,000 shares at March 31, 2013 and 2012; Issued: 4,722 and 2,983 shares at March 31, 2014 and 2013, respectively; Outstanding: 4,626 and 2,887 shares at March 31, 2014 and 2013, respectively	4	4
Additional paid-in capital	278,083	267,339
Treasury stock at cost - 96 shares at March 31, 2014 and 2013	-472	-472
Accumulated deficit	-274,530	-266,351
Total stockholders' equity	3,085	520
Total liabilities, redeemable convertible preferred stock and stockholders' equity	$21,800	$16,852

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, except Share data, unless otherwise specified
Accounts receivable, allowance for doubtful accounts (in Dollars)	$247	$111
Convertible preferred stock,par value (in Dollars per share)	$0.00	'
Convertible preferred stock,Issued	'	0
Convertible preferred stock,Outstanding	'	0
Series D Preferred Stock [Member]	'	'
Convertible preferred stock,par value (in Dollars per share)	$0.00	'
Convertible preferred stock,Issued	680,047	'
Convertible preferred stock,Outstanding	680,047	'
Common stock, par value (in Dollars per share)	$0.00	$0.00
Common stock,Authorized Shares	15,000,000	15,000,000
Common stock, Issued	4,722,000	2,983,000
Common stock, Outstanding	4,626,000	2,887,000
Treasury stock at cost b shares	96,000	96,000

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Revenues:	'	'
Total revenues	$15,789	$17,559
Cost of revenues:	'	'
Total cost of revenues	8,411	7,425
Gross profit:	'	'
Total gross profit	7,378	10,134
Operating expenses:	'	'
Research and development	2,993	3,706
Sales and marketing	8,313	6,708
General and administrative	4,984	3,618
Restructuring costs	227	331
Fees related to comprehensive settlement agreement	'	500
Total operating expenses	16,517	14,863
Loss from operations	-9,139	-4,729
Decrease in fair value of warrant liability	982	'
Other income (expense), net	-22	-20
Loss before provision for income taxes	-8,179	-4,749
Net loss	-8,179	-4,749
Net loss attributable to common stockholders	-11,692	-4,749
Basic and diluted net loss per common share attributable to common stockholders (in Dollars per share)	($2.18)	($1.68)
Weighted-average shares of common stock used in computing basic and diluted net loss per share attributable to common stockholders (in Shares)	3,756	2,827
Series C and Series D Preferred Stock [Member]	'	'
Operating expenses:	'	'
Series C and D redeemable preferred stock accretion	3,513	'
Recurring [Member]	'	'
Revenues:	'	'
Total revenues	12,210	11,773
Cost of revenues:	'	'
Total cost of revenues	2,673	2,006
Gross profit:	'	'
Total gross profit	9,537	9,767
Non-Recurring [Member]	'	'
Revenues:	'	'
Total revenues	3,579	5,786
Cost of revenues:	'	'
Total cost of revenues	5,738	5,419
Gross profit:	'	'
Total gross profit	($2,159)	$367

Consolidated_Statements_Of_Sto

Consolidated Statements Of Stockholdersb Equity (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Balance at March 31	$3,085,000	$520,000	$4,438,000
Stock-based compensation expense	'	1,129,000	'
Issuance of common stock	'	-36,000	'
Warrants to purchase common stock issued in connection with Series D private placement	1,789,000	'	'
ESPP purchase	257,000	'	'
Reclassification of warrants from liability to equity upon modification	1,286,000	'	'
Issuance of restricted stock, net of repurchase	-233,000	-262,000	'
Exercise of stock options	-19,000	'	'
Stock-based compensation expense	1,149,000	'	'
Net Income / loss	-8,179,000	-4,749,000	'
Redeemable Preferred Stock [Member] | Series C Preferred Stock [Member]	'	'	'
Issuance of common stock, mandatory redeemable preferred stock, and warrants through a private placement.	846,000	'	'
Issuance of common stock, mandatory redeemable preferred stock, and warrants through a private placement. (in Shares)	232,000	'	'
Value of benefical conversion feature	-846,000	'	'
Accretion of preferred stock to redemption value	1,621,000	'	'
Conversion of Series C redeemable preferred stock to common stock	-1,621,000	'	'
Conversion of Series C redeemable preferred stock to common stock (in Shares)	-232,000	'	'
Redeemable Preferred Stock [Member] | Series D Preferred Stock [Member]	'	'	'
Issuance of common stock, mandatory redeemable preferred stock, and warrants through a private placement.	3,106,000	'	'
Issuance of common stock, mandatory redeemable preferred stock, and warrants through a private placement. (in Shares)	680,000	'	'
Value of benefical conversion feature	-1,345,000	'	'
Accretion of preferred stock to redemption value	1,892,000	'	'
Redeemable Preferred Stock [Member]	'	'	'
Balance at March 31	3,653,000	'	'
Balance at March 31 (in Shares)	680,000	'	'
Common Stock [Member] | Series C Preferred Stock [Member]	'	'	'
Issuance of common stock, mandatory redeemable preferred stock, and warrants through a private placement. (in Shares)	578,000	'	'
Conversion of Series C redeemable preferred stock to common stock (in Shares)	232,000	'	'
Common Stock [Member] | Series D Preferred Stock [Member]	'	'	'
Issuance of common stock, mandatory redeemable preferred stock, and warrants through a private placement. (in Shares)	777,000	'	'
Common Stock [Member]	'	'	'
Balance at March 31	4,000	4,000	4,000
Balance at March 31 (in Shares)	4,626,000	2,983,000	2,892,000
Issuance of common stock (in Shares)	'	5,000	'
ESPP purchase (in Shares)	38,000	'	'
Issuance of restricted stock, net of repurchase (in Shares)	15,000	86,000	'
Exercise of stock options (in Shares)	4,000	'	'
Additional Paid-in Capital [Member] | Series C Preferred Stock [Member]	'	'	'
Issuance of common stock, mandatory redeemable preferred stock, and warrants through a private placement.	3,567,000	'	'
Value of benefical conversion feature	-846,000	'	'
Accretion of preferred stock to redemption value	-775,000	'	'
Conversion of Series C redeemable preferred stock to common stock	1,621,000	'	'
Additional Paid-in Capital [Member] | Series D Preferred Stock [Member]	'	'	'
Issuance of common stock, mandatory redeemable preferred stock, and warrants through a private placement.	3,495,000	'	'
Value of benefical conversion feature	1,345,000	'	'
Accretion of preferred stock to redemption value	-1,892,000	'	'
Additional Paid-in Capital [Member]	'	'	'
Balance at March 31	278,083,000	267,339,000	266,508,000
Stock-based compensation expense	'	1,129,000	'
Issuance of common stock	'	-36,000	'
Warrants to purchase common stock issued in connection with Series D private placement	1,789,000	'	'
ESPP purchase	257,000	'	'
Reclassification of warrants from liability to equity upon modification	1,286,000	'	'
Issuance of restricted stock, net of repurchase	-233,000	-262,000	'
Exercise of stock options	-19,000	'	'
Stock-based compensation expense	1,149,000	'	'
Treasury Stock [Member]	'	'	'
Balance at March 31	472,000	472,000	472,000
Balance at March 31 (in Shares)	-96,000	-96,000	-96,000
Retained Earnings [Member]	'	'	'
Balance at March 31	-274,530,000	-266,351,000	-261,602,000
Net Income / loss	-8,179,000	-4,749,000	'
Series C Preferred Stock [Member]	'	'	'
Issuance of common stock, mandatory redeemable preferred stock, and warrants through a private placement.	4,145,000	'	'
Value of benefical conversion feature	-846,000	'	'
Accretion of preferred stock to redemption value	-775,000	'	'
Conversion of Series C redeemable preferred stock to common stock	1,621,000	'	'
Series D Preferred Stock [Member]	'	'	'
Balance at March 31	3,085,000	520,000	'
Issuance of common stock, mandatory redeemable preferred stock, and warrants through a private placement.	4,272,000	'	'
Value of benefical conversion feature	1,345,000	'	'
Accretion of preferred stock to redemption value	($1,892,000)	'	'

Consolidated_Statements_Of_Sto1

Consolidated Statements Of Stockholdersb Equity (Parentheticals) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014
Series C Preferred Stock [Member]	'
Net of Issuance costs.	$437,000
Series D Preferred Stock [Member]	'
Net of Issuance costs.	$286,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Cash Flows (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Operating activities	'	'
Net loss	($8,179)	($4,749)
Depreciation	246	214
Loss on disposition of property and equipment	23	'
Stock-based compensation expense	1,149	1,129
Change in fair value of warrant liability	-982	'
Changes in assets and liabilities:	'	'
Accounts receivable (net)	449	-1,009
Prepaid expenses and other current assets	164	-322
Other assets	9	'
Accounts payable	359	615
Accrued restructuring costs	-232	232
Accrued payroll and related liabilities	-334	-789
Other accrued liabilities and long term liabilities	162	54
Deferred revenue	-2,177	1,204
Net cash used in operating activities	-9,343	-3,421
Investing activities	'	'
Purchase of property and equipment	-121	-259
Capitalized software	-910	'
Proceeds from maturities of short-term investments	'	199
Net cash used in investing activities	-1,031	-60
Financing activities	'	'
Issuance of common stock under employee stock plan	239	'
Proceeds from sale of common stock, preferred stock and warrants, net of issuance costs	14,227	'
Borrowings under credit facility, net	949	'
Employee taxes paid in exchange for restricted stock awards forefeited	-232	-298
Net cash (used in) provided by financing activities	15,183	-298
Net increase/(decrease) in cash and cash equivalents	4,809	-3,779
Cash and cash equivalents at beginning of the period	12,098	15,877
Cash and cash equivalents at end of the period	16,907	12,098
Supplemental disclosure of cash flow information:	'	'
Cash paid for interest	$35	'

Note_1_Summary_of_Business

Note 1 - Summary of Business	12 Months Ended
	Mar. 31, 2014
Disclosure Text Block [Abstract]	'
Basis of Accounting [Text Block]	'
	1.     Summary of Business
	Selectica, Inc. (the “Company” or “Selectica”) is a market and technology leader in cloud-based solutions that helps growing companies to close deals faster, more profitably, and with lower risk. Selectica is committed to making its customers successful by developing innovative software that the world’s most successful companies rely on to improve the effectiveness of their sales and contracting processes. Founded in 1996, the Company was originally organized to provide configuration, pricing management and quoting solutions for automating customers’ opportunity to order process. In May 2005, the Company purchased Determine Software, Inc. and entered the contract management software business. The Company's software solutions are based on patented technologies delivered through the cloud, making it easy for customers in industries like high-tech, telecommunications, manufacturing, healthcare, financial services, and government contracting to overcome product and channel complexity, increase deal value, and accelerate time to revenue.

Note_2_Summary_of_Significant_

Note 2 - Summary of Significant Policies	12 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Significant Accounting Policies [Text Block]	'
	2.     Summary of Significant Policies
	Principles of Consolidation
	The consolidated financial statements include all accounts of the Company and those of its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated.
	Use of Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
	Fair value of financial instruments
	The carrying amounts of the Company’s cash and cash equivalents, accounts receivable, accounts payable and other current liabilities approximate their fair values.
	Concentrations of Credit Risk
	Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents, short-term investments, and accounts receivable. The Company places its short-term investments in high-credit quality financial institutions. The Company is exposed to credit risk in the event of default by these institutions to the extent of the amount recorded on the balance sheet. The Company’s cash balances periodically exceed the FDIC insured amounts. Investments are not protected by FDIC insurance.  Accounts receivable are derived from revenue earned from customers primarily located in the United States. The Company performs ongoing credit evaluations of its customers’ financial condition and generally does not require collateral. The Company maintains reserves for potential credit losses, and historically, such losses have not been significant.
	Cash Equivalents and Short-term Investments
	The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company’s cash equivalents consist of money market funds, certificates of deposits, and commercial paper.  Fair values of cash equivalents approximated original cost due to the short period of time to maturity. The cost of securities sold is based on the specific identification method. The Company’s investment policy limits the amount of credit exposure to any one issuer of debt securities.
	The Company monitors its investments for impairment on a quarterly basis and determines whether a decline in fair value is other-than-temporary by considering factors such as current economic and market conditions, the credit rating of the issuers, the length of time an investment has been below the Company’s carrying value, and the Company’s ability and intent to hold the investment to maturity. If a decline in fair value, caused by factors other than changes in interest rates, is determined to be other-than-temporary, an adjustment is recorded and charged to operations.
	Accounts Receivable and Allowance for Doubtful Accounts
	The Company evaluates the collectability of its accounts receivable based on a combination of factors. When the Company believes a collectability issue exists with respect to a specific receivable, the Company records an allowance to reduce that receivable to the amount that it believes to be collectible. In making the evaluations, the Company will consider the collection history with the customer, the customer’s credit rating, communications with the customer as to reasons for the delay in payment, disputes or claims filed by the customer, warranty claims, non-responsiveness of customers to collection calls, and feedback from the responsible sales contact. In addition, the Company will also consider general economic conditions, the age of the receivable and the quality of the collection efforts.
	Property and Equipment
	Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method based on estimated useful lives. The estimated useful lives for computer software and equipment is three years, furniture and fixtures is five years, and leasehold improvements is the shorter of the applicable lease term or estimated useful life.
	Revenue Recognition
	The Company generates revenues by providing its SaaS solutions through subscription license arrangements and related professional services, as well as through perpetual and term licenses and related software maintenance and professional services. The Company presents revenue net of sales taxes and any similar assessments.
	Customer Concentrations
	A limited number of customers have historically accounted for a substantial portion of the Company’s revenues. The following table presents customers that accounted for more than 10% of revenue for the last two fiscal years:
		2014			2013
	Customer A		14	%		13	%
	Customers who accounted for at least 10% of gross accounts receivable were as follows:
		Fiscal Years Ended March 31,
		2014			2013
	Customer B		29	%		22	%
	Revenue recognition criteria. The Company recognizes revenue when (1) persuasive evidence of an arrangement exists, (2) delivery has occurred or services have been rendered, (3) fees are fixed or determinable and (4) collectability is probable. If we determine that any one of the four criteria is not met, the Company will defer recognition of revenue until all the criteria are met.
	Multiple-Deliverable Arrangements. The Company enters into arrangements with multiple-deliverables that generally include subscription, support and professional services. If a deliverable has standalone value, and delivery is probable and within the Company’s control, the Company accounts for the deliverable as a separate unit of accounting. Subscription services have standalone value as such services are often sold separately, primarily through renewals. Professional services have standalone value as such services are often sold separately, and are available from other vendors.
	Upon separating the multiple-deliverables into separate units of accounting, the arrangement consideration is allocated to the identified separate units based on a relative selling price hierarchy. The Company determines the relative selling price for a deliverable based on its vendor-specific objective evidence of selling price (“VSOE”), if available, or its best estimate of selling price (“BESP”), if VSOE is not available. The Company has determined that third-party evidence of selling price (“TPE”) is not a practical alternative due to differences in its service offerings compared to other parties and the availability of relevant third-party pricing information. The amount of revenue allocated to delivered items is limited by contingent revenue, if any.
	For professional services, the Company has established VSOE as a consistent number of standalone sales of this deliverable have been priced within a reasonably narrow range. The Company has not established VSOE for its subscription services due to lack of pricing consistency, and other factors. Accordingly, the Company uses its BESP to determine the relative selling price.
	The Company determined BESP by considering its price list, as well as overall pricing objectives and market conditions. Significant pricing practices taken into consideration include the Company’s discounting practices, contract prices per user, the size and volume of the Company’s transactions, the customer demographic, and its market strategy.
	Recurring revenues. Recurring revenues consist of subscription license sales, maintenance revenues from previously sold perpetual licenses, and hosting revenues. Recurring revenues are recognized ratably over the stated contractual period.
	Non-recurring revenues.  Non-recurring revenues are comprised of revenues from professional services for system implementations, enhancements, and training, and perpetual license sales prior to fiscal 2014. For professional services arrangements billed on a time-and-materials basis, services are recognized as revenue as the services are rendered. For fixed-fee professional service arrangements, the Company recognizes revenue under the proportional performance method of accounting and estimates the proportional performance utilizing hours incurred to date as a percentage of total estimated hours to complete the project. If the Company does not have a sufficient basis to measure progress toward completion, revenue is recognized upon completion. The Company recognizes a loss for a fixed-fee professional service if the total estimated project costs exceed project revenues. Perpetual license sales are recognized upon delivery of the product, assuming all the other conditions for revenue recognition have been met.
	In certain arrangements with non-standard acceptance criteria, the Company defers the revenue until the acceptance criteria are satisfied. Reimbursements, including those related to travel and out-of-pocket expenses are included in non-recurring revenues, and an equivalent amount of reimbursable expenses is included in non-recurring cost of revenues.
	Non-recurring revenues in fiscal year 2014 were comprised of $3.6 million in professional services revenues and zero perpetual license revenues. Non-recurring revenues in fiscal year 2013 were comprised of $5.4 million in professional services and $0.4 million in perpetual license revenues.
	Customer Concentrations
	A limited number of customers have historically accounted for a substantial portion of the Company’s revenues. The following table presents customers that accounted for more than 10% of revenue for the last two fiscal years:
	Advertising Expense
	The cost of advertising is expensed as incurred. Advertising expense for the years ended March 31, 2014 and 2013 was approximately $209,000 and $118,000 respectively.
	Software Development Costs
	Software development costs incurred prior to the establishment of technological feasibility are included in research and development expenses. The Company defines establishment of technological feasibility as the completion of a working model. Software development costs incurred subsequent to the establishment of technological feasibility through the period of general market availability of the products are capitalized, if material, after consideration of various factors, including net realizable value.
	Stock-Based Compensation
	The Company recognizes stock-based compensation expense for only those awards ultimately expected to vest on a straight-line basis over the requisite service period of the award, net of an estimated forfeiture rate. The Company estimates the fair value of stock options using a Black-Scholes valuation model, which requires the input of highly subjective assumptions, including the option’s expected term and stock price volatility. In addition, judgment is also required in estimating the number of stock-based awards that are expected to be forfeited. Forfeitures are estimated based on historical experience at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management’s judgment. As a result, if factors change and the Company uses different assumptions, its stock-based compensation expense could be materially different in the future.
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS, Continued
	Geographic Information:
	International revenues are attributable to countries based on the location of the customers. For the fiscal years ended March 31, 2014 and 2013, sales to international locations were derived primarily from Canada, India, New Zealand, Switzerland and the United Kingdom.
		Fiscal Years Ended March 31,
		2014			2013
		(in thousands, except percentages)
	International Revenues		10	%		12	%
	Domestic Revenues		90	%		88	%
	Total Revenues		100	%		100	%
	For the years ended March 31, 2014 and 2013, the Company held long-lived assets outside of the United States with a net book value of approximately $67,000 and $126,000, respectively. These assets were located in Odessa, Ukraine.
	Treasury Stock
	There were no stock repurchases other than from employees during fiscal year 2014.
	The Company had 96,000 shares of treasury stock as of March 31, 2014 and March 31, 2013.
	Recent Accounting Pronouncements
	In May 2014, the FASB and the International Accounting Standards Board (IASB) issued, ASU 2014-09 (Topic 606) Revenue from Contracts with Customers. The guidance substantially converges final standards on revenue recognition between the FASB and IASB providing a framework on addressing revenue recognition issues and, upon its effective date, replaces almost all existing revenue recognition guidance, including industry-specific guidance, in current U.S. generally accepted accounting principles. The ASU is effective for annual reporting periods beginning after December 15, 2016. We are currently evaluating the impact of adopting ASU 2014-09 to determine the impact, if any, it may have on our current practices.

Note_3_Private_Placement_Fundi

Note 3 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants	12 Months Ended
	Mar. 31, 2014
Private Placement Funding With Redeemable Convertible Preferred Stock And Warrants [Abstract]	'
Private Placement Funding With Redeemable Convertible Preferred Stock And Warrants	'
	3.     Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants
	On May 31, 2013, in connection with the first closing of a private placement equity financing (the “2013 Financing”), the Company sold and issued 577,105 shares of our common stock (the “Common Shares”), and 231,518 shares of our newly created redeemable Series C Convertible Preferred Stock (the “Series C Stock”), to certain institutional funds and other accredited investors (“2013 Investors”) at a purchase price of $7.00 per share. The Series C Stock automatically converted into 231,518 shares of common stock upon stockholder approval at the annual meeting on September 10, 2013. Had the Series C Stock not converted into common stock, the Series C Stock would have been redeemable at the option of the holder and was therefore recorded in temporary equity until September 10, 2013. In addition, the Company issued to the 2013 Investors Series A Warrants to purchase common stock, as amended on September 4, 2013 (the “Series A Warrants”), initially exercisable for 404,309 shares of common stock. The exercise price of the Series A Warrants is $7.75 per share. The Series A Warrants have a five-year term and first became exercisable on November 30, 2013, six months following the date of issuance. Prior to amendment on September 4, 2013, the Series A Warrants had an exercise price of $8.75 per share and had a potential adjustment to the warrant exercise price that could result in the event we issued securities at a price below the then current exercise price. In addition, the amendment removed a cash settlement provision in the case of a Fundamental Transaction, as defined in the Warrant agreement.
	On September 12, 2013, in connection with the second closing (the “Second Closing”) of the 2013 Financing, the Company sold and issued 91,144 shares of its common stock at a purchase price per share of $7.00 to certain members of management and the Board of Directors of the Company (the “Second Closing Investors”). The $0.6 million aggregate gross purchase price was received in cash and recorded in stockholders’ equity. In addition, at the Second Closing the Company issued to each Second Closing Investor a Series B warrant to purchase common stock (the “Series B Warrants”), initially exercisable for 45,571 shares of common stock. The exercise price of the Series B Warrants is $7.75 per share. The warrants have a five-year term, and are not exercisable for the first six months following the date of issuance. The Company has evaluated the Series B Warrants issued in the Financing and has concluded that equity classification is appropriate as all such warrants are considered to be indexed to the Company’s equity and there are no settlement provisions that would result in classification as a debt instrument.
	On January 24, 2014, in connection with the closing of an additional private placement equity financing (the “January 2014 Financing”), the Company sold and issued 765,605 shares of its common stock and 680,047 shares of its newly created Series D Convertible Preferred Stock (“Series D Stock”) to certain institutional funds and other accredited investors (including certain of the 2013 Investors) (the “2014 Investors”) at a purchase price of $6.00 per Common Share and $60.00 per whole share of Series D Stock (or $6.00 per one-tenth (1/10) of a share of Series D Stock, which would convert into one share of Common Stock as described below). In addition, the Company issued to the 2014 Investors warrants to purchase common stock, initially exercisable for an aggregate of 723,030 shares of common stock (the “2014 Warrants”). The exercise price of the 2014 Warrants is $7.00 per share. The 2014 Warrants have a five-year term and will become exercisable on July 24, 2014, six months following the date of issuance.
	In connection with the 2013 Financing and January 2014 Financing, the Company issued to Lake Street Capital Markets, LLC, who served as the placement agent in both financings, 20,833 shares of its common stock and warrants to purchase an aggregate of 37,679 shares of common stock.
		(a)	Presentation of Series A and 2014 Warrants
	Prior to amendment on September 4, 2013, the potential adjustment to the Series A Warrant exercise price precluded the warrants from meeting the criteria set forth in ASC 815-40, “Derivatives and Hedging – Contracts in Entity’s own Stock” to be considered indexed to the Company’s own stock. Accordingly, the fair value of the Series A Warrants was initially recorded as a liability. We estimated the fair value of these warrants at the May 31, 2013 issuance date using the Black-Scholes model and revalued the Series A Warrants as of June 30, 2013 and upon amendment on September 4, 2013 when the Series A Warrants were no longer required to be reported as a liability and were reclassified to equity using the September 4, 2013 Black-Sholes value of $1.3 million. The Black-Scholes model requires the input of highly subjective assumptions, including the warrant’s risk free rate and stock price volatility. The change in the fair value of the Series A Warrants was recognized in the statements of operations within non-operating income (expense).
	The Company has evaluated the 2014 Warrants and has concluded that equity classification is appropriate as all such 2014 Warrants are considered to be indexed to the Company’s equity and there are no settlement provisions that would result in classification as a debt instrument.
		(b)	Presentation of Redeemable Convertible Preferred Stock
	Because the Series C Stock was redeemable at the option of the holder (had the stockholders not approved conversion on September 10, 2013 as discussed above), the Company recorded the Series C Stock in temporary equity until conversion on September 10, 2013 when the redemption value of $1.6 million was reclassified to stockholders’ equity.
	Pursuant to the Certificate of Designations, Preferences and Rights of Series D Convertible Preferred Stock filed by the Company with the Delaware Secretary of State on January 23, 2014 (the “Certificate of Designation”), after stockholder approval, each whole share of Series D Stock converted automatically into ten shares of Common Stock at a conversion price of $6.00 per share of Common Stock.
	The Series D Stock was not entitled to a liquidation or dividend preference. If the Series D Stock had not been converted into Common Stock following stockholder approval in April 2014, beginning on April 15, 2014, the Series D Stock would have been entitled to 10% accruing dividends per annum. The dividends would have been payable quarterly in cash, beginning on June 30, 2014. The shares of Series D Stock were also redeemable by the Company upon the request of the holders of at least a majority of the then outstanding Series D Stock. The redemption price would have been equal to the product of (i) the number of shares or fraction of a share of Series D Preferred Stock to be redeemed from each such holder multiplied by (ii) ten (10) times the conversion price then in effect, plus any accrued and unpaid dividends up to, but not including, the redemption date.
	The holders of Series D Stock had the right to vote together with the holders of the Company’s Common Stock as a single class on any matter on which the holders of Common Stock were entitled to vote, except that the holders of Series D Stock were not eligible to vote their shares of Series D Stock on the proposal submitted to the Company’s stockholders for approval of the issuance and sale of the securities in the Financing and the conversion of the Series D Stock. Holders of Series D Stock were entitled to cast a fraction of one vote for each share of Common Stock issuable to such holder on the record date for the determination of stockholders entitled to vote at a conversion rate the numerator of which was $60.00 and the denominator of which was the closing bid price per share of the Common Stock on January 24, 2014, as reported by Bloomberg Financial Markets.
	On April 10, 2014, following approval by the Company’s stockholders, each whole share of Series D Stock converted automatically into ten shares of Common Stock at an initial conversion price of $6.00 per share of Common Stock, for a total of 690,274 shares of Common Stock issued upon such conversion (including the conversion of the shares of Series D Stock issued to Lake Street as described above). Because the Series D Stock was redeemable at the option of the holder, the Company has recorded it in temporary equity as of March 31, 2014.
		(c)	Beneficial Conversion Feature (“BCF”)
	The Series C and Series D Stock was assessed under ASC 470, “Debt,” and the Company determined that the conversion to common stock qualifies as a BCF since it had a nondetachable conversion feature that was in the money at the commitment date. The BCF computation compares the carrying value of the preferred stock after the value of any derivatives has been allocated from the proceeds (in this case, the warrant liability) to the transaction date value of the number of shares that the holder can convert into. The calculation resulted in a BCF of $0.5 million. The BCF was recorded in additional paid-in capital.
		(d)	Carrying Values
	The proceeds of the 2013 Financing were allocated first to the fair value of the warrants and then to the common stock and Series C Stock sold on a pro rata basis. The Company accreted the Series C Stock to its redemption value, which was $1.6 million based upon the 231,518 shares sold multiplied by the $7.00 per share redemption price. Accretion was calculated through September 10, 2013 the earliest possible redemption date. The proceeds of the 2014 Financing for Series D Stock were allocated to the common stock, the 2014 Warrants and Series D Stock sold on a pro rata basis.
	The following table shows the allocation of proceeds from the 2013 Investors and 2014 Investors and carrying value of the Series C Stock and Series D Stock. Series C Stock was reclassified to stockholders’ equity upon conversion to common stock on September 10, 2013 (in thousands, except per share amounts):
	Gross proceeds on May 31, 2013		$	5,660
	Fair value of warrants on May 31, 2013			(2,268	)
	Gross proceeds to allocate to common stock and Series C Stock		$	3,392
	Gross proceeds allocated to common shares sold		$	2,421
	Related transaction costs allocated			(313	)
	Net value allocated to common shares sold		$	2,108
	Gross proceeds allocated to Series C Stock sold on May 31, 2013		$	971
	Related transaction costs allocated			(125	)
	Net value allocated to Series C Stock sold prior to BCF			846
	Calculated BCF value			(846	)
	Accretion of Series C Stock through September 10, 2013			1,621
	Carrying value of Series C Stock recalssified upon conversion to common stock		$	1,621
	Gross proceeds on January 24, 2014		$	8,676
	Fair value of warrants on January 24,2014			(1,789	)
	Gross proceeds to allocate to common stock and Series D Stock		$	6,887
	Gross proceeds allocated to common shares sold		$	3,646
	Related transaction costs allocated			(151	)
	Net value allocated to common shares sold		$	3,495
	Gross proceeds allocated to Series D Stock sold on January 24, 2014		$	3,241
	Related transaction costs allocated			(135	)
	Net value allocated to Series D Stock sold prior to BCF			3,106
	Calculated BCF value			(1,345	)
	Accretion of Series D Stock through March 31, 2014			1,892
	Carrying value of Series D Stock as of March 31, 2014		$	3,653

Note_4_Property_and_Equipment

Note 4 - Property and Equipment	12 Months Ended
	Mar. 31, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	4.     Property and Equipment
	Property and equipment consist of the following:
		March 31,
		2014			2013
		(in thousands)
	Computers and software	$	2,381		$	2,962
	Furniture and equipment		774			734
	Leasehold improvements		117			115
			3,272			3,811
	Less: accumulated depreciation		(2,960	)		(3,404	)
	Total property and equipment, net	$	312		$	407
	Depreciation expense related to property and equipment was approximately $158,000 and $214,000 for the years ended March 31, 2014 and 2013, respectively.

Note_5_Capitalized_Software

Note 5 - Capitalized Software	12 Months Ended
	Mar. 31, 2014
Research and Development [Abstract]	'
Research, Development, and Computer Software Disclosure [Text Block]	'
	5.     Capitalized Software
	The Company capitalizes software development costs upon achieving technological feasibility of the related products. Software development costs incurred prior to achieving technological feasibility are charged to engineering and product development expense as incurred.
	Capitalized software will be amortized once the product is available for general release, using the straight-line method over the estimated useful lives of the assets, which is three years. The recoverability of capitalized software is evaluated for recoverability based on estimated future gross revenues reduced by the associated costs. If gross revenues were to be significantly less than estimated, the net realizable value of the capitalized software intended for sale would be impaired, which could result in the write-off of all or a portion of the unamortized balance of such capitalized software.
	Amortization expense was $0.01 million for the year ended March 31, 2014 and is included in the product cost of revenue. Prior to the year ended March 31, 2014, these costs were not capitalized due to the short length of time between technological feasibility and general availability of software versions. The unamortized balance of capitalized software was $0.9 million as of March 31, 2014.

Note_6_Accrued_and_Other_Liabi

Note 6 - Accrued and Other Liabilities	12 Months Ended
	Mar. 31, 2014
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]	'
Other Liabilities Disclosure [Text Block]	'
	6.     Accrued and Other Liabilities
	As of March 31, 2014 and 2013, accrued payroll and deferred revenue consisted of the following:
		2014		2013
		(in thousands)
	Accrued payroll and related liabilities:
	Accrued vacation	$	371	$	359
	Accrued bonus		164		287
	Accrued salaries and wages		92		86
	Accrued commissions		21		250
	Total	$	648	$	982
		2014		2013
		(in thousands)
	Deferred revenue:
	License	$	—	$	—
	Hosting		85		84
	Consulting		138		296
	Subscription		2,482		2,126
	Maintenance		2,426		3,647
	Total	$	5,131	$	6,153
		2014		2013
		(in thousands)
	Long-term deferred revenue:
	Subscription	$	168	$	766
	Maintenance		450		1,006
	Total	$	618	$	1,772

Note_7_Restructuring

Note 7 - Restructuring	12 Months Ended
	Mar. 31, 2014
Restructuring and Related Activities [Abstract]	'
Restructuring and Related Activities Disclosure [Text Block]	'
	7.  Restructuring
	During the second quarter of fiscal 2014, the Company initiated a restructuring plan to reorganize its operations. The Company incurred $0.2 million in severance costs under this plan, all of which was paid in fiscal 2014.
	During the fourth quarter of fiscal 2013, the Company initiated a restructuring plan to reorganize its operations in-line with its conversion to a SaaS model. The Company incurred $0.3 million in severance costs under this plan, of which $0.1 million was paid in fiscal 2013 and $0.2 million was paid during the first nine months of fiscal 2014.

Note_8_Operating_Lease_Commitm

Note 8 - Operating Lease Commitments	12 Months Ended
	Mar. 31, 2014
Leases, Operating [Abstract]	'
Operating Leases of Lessee Disclosure [Table Text Block]	'
	8.  Operating Lease Commitments
	On May 15, 2014, Selectica, Inc. (the “Company”) entered into a First Amendment to Lease (the “Lease Amendment”) with SKBGS I, L.L.C. amending the Office Lease dated July 8, 2011 whereby the Company is leasing approximately 10,516 square feet of office space at a premises located at 2121 South El Camino Real, Suite 1000, San Mateo, California where the Company maintains its headquarters. The Lease Amendment extends the lease term to cover a 25 month period expiring January 31, 2017 and carries a base rent of $2.85 per rentable square foot, escalating 3% each year.
	Rental expenses for the office space and equipment were approximately $0.2 million for both years ended March 31, 2014 and 2013. Minimum payments under our operating leases agreements are $0.2 million in fiscal 2015, $0.4 million in fiscal 2016 and $0.3 million in fiscal 2017.

Note_9_Contingencies

Note 9 - Contingencies	12 Months Ended
	Mar. 31, 2014
Disclosure Text Block Supplement [Abstract]	'
Legal Matters and Contingencies [Text Block]	'
	9.  Contingencies
	Legal Matters
	On December 22, 2008, the Company filed suit in the Court of Chancery of the State of Delaware against Trilogy, Inc. and certain related parties (“Trilogy”) seeking declaratory relief that the Company’s Rights Agreement as amended on November 16, 2008 was an appropriate measure to protect a valuable asset – the Company’s net operating loss carryforwards and related tax credits – from being limited as to utilization as provided under Section 382 of the Internal Revenue Code (IRC) which could in turn substantially reduce the value of that asset to all of the Company’s shareholders. The Company sued Trilogy after (i) it amended the Rights Agreement on November 16, 2008 to reduce the ownership threshold from 15% to 4.99%, with existing 5% or greater shareholders limited to acquiring no more than an additional 0.5% and (ii) despite the ownership threshold, Trilogy increased its beneficial ownership by 0.51% to 6.71% as announced in its 13(d) filing with the SEC on December 22, 2008. As a result, on January 2, 2009, a special committee of the Company’s Board of Directors declared Trilogy an “Acquiring Person” under the Rights Agreement, exchanged the rights (other than those belonging to Trilogy) for new shares of common stock under the Exchange Provision in the Rights Agreement, adopted an amended Rights Agreement and declared a new dividend of rights under the amended Rights Agreement. On January 16, 2009, the defendants in this action, Trilogy, filed an answer to the Company’s complaint and a counterclaim alleging that the Company’s Board of Directors had breached fiduciary duties in amending the Rights Agreement, in exchanging the rights, in adopting the amended Rights Agreement and in declaring a new dividend of rights. The Company, and its Board of Directors, believes that the actions taken were lawful and appropriate under the circumstances and in the interest of all the Company’s shareholders and therefore the allegations of the counterclaim were without merit. The counterclaim asked for various measures of equitable relief and also included a claim for punitive or exemplary damages, which are not available in Delaware. The case was tried in the Delaware Court of Chancery in 2009. On February 26, 2010, the Delaware Court of Chancery issued a memorandum opinion that determined, among other things (i) that the actions taken by the Company’s Board of Directors and its special committee were lawful and appropriate under the circumstances, and (ii) that Trilogy was not entitled to relief for its counterclaims. An appeal from this decision was filed with the Delaware Supreme Court.  On October 11, 2010, the Delaware Supreme Court issued an opinion that affirmed the Court of Chancery’s ruling in the Company’s favor, confirming the validity of the actions the Board of Directors and its special committee took to preserve the Company’s net operating losses. On November 11, 2010, the Company filed suit in the Delaware Court of Chancery against Trilogy seeking a declaratory judgment that the Company is not obligated to pay more than $1 million in fees demanded by Trilogy in connection with an alleged “investigation” into the Company’s corporate governance policies and procedures. On January 13, 2011, Trilogy answered the Company’s complaint and asserted a counterclaim for such fees. The Company filed a reply on February 2, 2011. On September 20, 2011, the Company and Trilogy entered into a Comprehensive Settlement Agreement (the “Settlement Agreement”) providing for both the settlement of existing claims as well as the restriction of future claims between the parties. The Settlement Agreement provides for, among other things, (i) the repayment by the Company of all outstanding amounts payable to Trilogy under the previous Settlement, Release and License Agreement dated October 5, 2007 entered into between the Company and Versata (the “2007 Settlement Agreement”), (ii) the purchase by the Company of all shares of Company common stock held by Versata and related standstill requirement whereby Versata would not be able to purchase any further shares of Company common stock for a 25 year period and (iii) the entry into a consulting agreement between the Company and one of Versata’s affiliated entities whereby the Company could utilize certain services of such entity. Each party provided a general release of claims to the other party with respect to any and all claims that such party (or any of its affiliates) may have against the other party occurring before the date of the Settlement Agreement, and the parties entered into a covenant not to sue each other. As a result of the Settlement Agreement, the claims and counterclaims referenced above were dismissed by the parties.
	As the costs of this litigation and related legal work are directly related to the issuance of shares under the Company’s Rights Agreement, these costs have been charged as issuance costs against the additional paid-in capital (APIC) account on the Company’s balance sheet, less a reserve for both received and anticipated recoveries from the Company’s Director’s and Officer’s insurance policy. As of March 31, 2014, there are no longer anticipated recoveries reflected in prepaid expenses and other current assets on the Company’s balance sheet.
	Warranties and Indemnifications
	The Company’s products are generally warranted to perform substantially in accordance with the functional specifications set forth in the associated product documentation for a period of 90 days. In the event there is a failure of such warranties, the Company generally is obligated to correct the product to conform to the product documentation or, if the Company is unable to do so, the customer is entitled to seek a refund of the purchase price of the product or service. The Company has not provided for a warranty accrual as of March 31, 2014 and 2013. To date, the Company has not refunded any amounts in relation to the warranty.
	The Company generally agrees to indemnify its customers against legal claims that the Company’s software infringes certain third-party intellectual property rights. In the event of such a claim, the Company is obligated to defend its customer against the claim and to either settle the claim at the Company’s expense or pay damages that the customer is legally required to pay to the third-party claimant. In addition, in the event of the infringement, the Company agrees to modify or replace the infringing product, or, if those options are not reasonably possible, to refund the purchase price of the software. To date, the Company has not been required to make any payment resulting from infringement claims asserted against its customers. As such, the Company has not provided for an indemnification accrual as of March 31, 2014 and 2013.

Note_10_Stockholders_Equity

Note 10 - Stockholders' Equity	12 Months Ended
	Mar. 31, 2014
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	10.     Stockholders’ Equity
	Common Stock Reserved for Future Issuance
	At March 31, 2014, shares of common stock reserved for future issuance were as follows:
	Equity incentive plans:
	Awards outstanding		639,000
	Options outstanding		386,000
	Reserved for future grants		555,000
	Total common stock reserved for future issuance		1,580,000
	The effect of recording stock-based compensation expense for each of the periods presented was as follows:
		Fiscal Years Ended
		March 31,
		(in thousands)
		2014			2013
	Cost of revenues	$	250		$	134
	Research and development		167			171
	Sales and marketing		345			284
	General and administrative		385			540
	Impact on net loss	$	1,149		$	1,129
	As of March 31, 2014, the unrecorded share-based compensation balance related to stock options outstanding excluding estimated forfeitures was $0.6 million and will be recognized over an estimated weighted average amortization period of 2.80 years. As of March 31, 2014, the unrecorded share-based compensation balance related to stock awards outstanding excluding estimated forfeitures was $3.1 million and will be recognized over an estimated weighted average amortization period of 2.84 years. The amortization period is based on the expected remaining vesting term of the options or awards.
	1999 Employee Stock Purchase Plan (“ESPP”)
	In fiscal year 2014, the price paid for the Company’s common stock purchased under the ESPP was equal to 85% of the lower of the fair market value of the Company’s common stock at the beginning of each offering period or at the end of each offering period. The compensation expense in connection with the ESPP for the fiscal year ended March 31, 2014 was $114,000. During the fiscal year ended March 31, 2014 there were 37,553 shares issued under the ESPP at a weighted average purchase price of $0.00 per share.move391498097
	Redeemable Convertible Preferred Stock
	The Company is authorized to issue 1 million shares of preferred stock at a par value of $0.0001 per share. There were 680,047 shares of Series D redeemable convertible Stock issued and outstanding at March 31, 2014 and no preferred stock issued and outstanding at March 31, 2013.
	The Board of Directors has the authority, without action by the stockholders, to designate and issue the preferred stock in one or more series and to fix the rights, preferences, privileges, and related restrictions, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, redemption prices, liquidation preferences and the number of shares constituting any series or the designation of the series.
	The Series D Stock was not entitled to a liquidation or dividend preference. If the Series D Stock had not been converted into Common Stock following stockholder approval in April 2014, beginning on April 15, 2014, the Series D Stock would have been entitled to 10% accruing dividends per annum. The dividends would have been payable quarterly in cash, beginning on June 30, 2014. The shares of Series D Stock were also redeemable by the Company upon the request of the holders of at least a majority of the then outstanding Series D Stock. The redemption price would have been equal to the product of (i) the number of shares or fraction of a share of Series D Preferred Stock to be redeemed from each such holder multiplied by (ii) ten (10) times the conversion price then in effect, plus any accrued and unpaid dividends up to, but not including, the redemption date.
	The holders of Series D Stock had the right to vote together with the holders of the Company’s Common Stock as a single class on any matter on which the holders of Common Stock were entitled to vote, except that the holders of Series D Stock were not eligible to vote their shares of Series D Stock on the proposal submitted to the Company’s stockholders for approval of the issuance and sale of the securities in the Financing and the conversion of the Series D Stock. Holders of Series D Stock were entitled to cast a fraction of one vote for each share of Common Stock issuable to such holder on the record date for the determination of stockholders entitled to vote at a conversion rate the numerator of which was $60.00 and the denominator of which was the closing bid price per share of the Common Stock on January 24, 2014, as reported by Bloomberg Financial Markets.
	On April 10, 2014, following approval by the Company’s stockholders, each whole share of Series D Stock converted automatically into ten shares of Common Stock at an initial conversion price of $6.00 per share of Common Stock, for a total of 690,274 shares of Common Stock issued upon such conversion (including the conversion of the shares of Series D Stock issued to Lake Street as described above). move391498099Because the Series D Stock was redeemable at the option of the holder (prior to the shareholders approving conversion on April 10, 2014 as discussed above), we have recorded it in temporary equity as of March 31, 2014.
	Stock Option Plans—Approved by Stockholders
	1996 Plan
	The Company adopted the 1996 Stock Plan as amended and restated March 28, 2001 (the “1996 Plan”). A total of approximately 815,000 shares of common stock have been reserved under the 1996 Plan. With limited restrictions, if shares awarded under the 1996 Plan are forfeited, those shares will again become available for new awards under the 1996 Plan. The 1996 Plan permits the grant of options, stock appreciation rights, shares of restricted stock, and stock units. The types of options include incentive stock options that qualify for favorable tax treatment for the optionee under Section 422 of the Internal Revenue Code of 1986, and non-statutory stock options not designed to qualify for favorable tax treatment. Employees, non-employee members of the board and consultants are eligible to participate in the 1996 Plan. Incentive stock options are granted at an exercise price of not less than 100% of the fair market value per share of the common stock on the date of grant, and non-statutory stock options are granted at an exercise price of not less than 85% of the fair market value per share on the date of grant. Options generally vest with respect to 25% of the shares one year after the options’ vesting commencement date and the remainder vest in equal monthly installments over the following 36 months. Options granted under the 1996 Plan have a maximum term of ten years.
	1999 Equity Incentive Plan
	The Company adopted the 1999 Equity Incentive Plan (the “1999 Plan”) on November 18, 1999. The 1999 Plan was amended in May 2010, such that the number of shares reserved for issuance is no longer automatically increased, and a total of 1,551,000 shares were reserved for future issuance. With limited restrictions, if shares awarded under the 1999 Plan are forfeited, those shares will again become available for new awards under the 1999 Plan. The 1999 Plan permits the grant of options, stock appreciation rights, shares of restricted stock, and stock units. The types of options include incentive stock options that qualify for favorable tax treatment for the optionee under Section 422 of the Internal Revenue Code of 1986 and non-statutory stock options not designed to qualify for favorable tax treatment. Employees, non-employee members of the Board of Directors and consultants are eligible to participate in the 1999 Plan. Each eligible participant is limited to being granted options or stock appreciation rights covering no more than 33,000 shares per fiscal year, except in the first year of employment where the limit is 66,000 shares. Incentive stock options are granted at an exercise price of not less than 100% of the fair market value per share of the common stock on the date of grant, and non-statutory stock options are granted at an exercise price of not less than 85% of the fair market value per share on the date of grant. Options generally vest with respect to 25% of the shares one year after the options’ vesting commencement date and the remainder vest in equal monthly installments over the following 36 months. Options granted under the 1999 Plan have a maximum term of ten years.
	On December 3, 2012, the Compensation Committee of the Board of Directors of the Company adopted a Long Term Performance Incentive Plan (the “LTPIP”) within the 1999 Equity Incentive Plan (the “1999 Plan”), under which restricted stock units would be granted to the Company’s executives. Under the LTPIP, sixty percent (60%) of the restricted stock units will vest based upon achievement of contracted monthly recurring revenue targets over a period of three years, with fifty percent (50%) of the amount withheld from vesting until the Company achieves profitability, and forty percent (40%) vest based upon operating profit targets over a period of three years. The restricted stock units granted under the LTPIP include 420,000 shares granted to the Company’s executives, under which the Company’s Chief Executive Officer received a grant of 220,000 restricted stock units, and the Company’s Chief Financial Officer, Chief Strategy Officer, Chief Operating Officer and Chief Commercial Officer each received a grant of 50,000 restricted stock units. The Company is amortizing the related compensation expense on a straight-line basis over the expected vesting period. The compensation expense was $0.1 million and $0.4 million for the years as of March 31, 2014 and 2013, respectively.
	1999 Employee Stock Purchase Plan
	On November 18, 1999, the Company’s Board of Directors approved the adoption of the 1999 Employee Stock Purchase Plan (the “Purchase Plan”) and the Company’s stockholders have approved of the Purchase Plan. The Purchase Plan was amended and restated on February 1, 2008 and amended and restated on November 7, 2012. A total of 100,000 shares of common stock were initially reserved for issuance under the Purchase Plan. The November 7, 2012 amendment and restatement of the Purchase Plan provided a reserve of 553,000 shares of common stock available for issuance under the Purchase Plan.
	The Compensation Committee of the Board of Directors administers this plan. The Purchase Plan is intended to qualify under Section 423 of the Internal Revenue Code. The Purchase Plan permits eligible employees to purchase common stock through payroll deductions, which may not exceed 15% of an employee’s cash compensation, at a purchase price equal to the lower of 85% of the fair market value of the Company’s common stock at the beginning of each offering period or at the end of each purchase period. Employees who work more than five months per year and more than twenty hours per week are eligible to participate in the Purchase Plan. Stockholders who own more than 5% of the Company’s outstanding common stock are excluded from participating in the Purchase Plan. Each eligible employee cannot purchase more than 5,000 shares per purchase date (10,000 shares per year) and, generally, cannot purchase more than $25,000 of stock per calendar year. Eligible employees may begin participating in the Purchase Plan at the start of an offering period. Each offering period lasts six months beginning on January 31 and July 31 of each calendar year with an additional one-time offering period beginning on or about November 1, 2012 and terminating on or about January 1, 2013. Employees may end their participation in the Purchase Plan at any time. Participation ends automatically upon termination of employment. The Board of Directors may amend or terminate the Purchase Plan at any time. If not terminated earlier, the Purchase Plan has a term of twenty years. If the Board of Directors increases the number of shares of common stock reserved for issuance under the Purchase Plan, other than any share increase resulting from the formula described in the previous paragraph, it must seek the approval of the Company’s stockholders.
	2001 Supplemental Plan
	We adopted the 2001 Supplemental Plan (the “Supplemental Plan”) on May 30, 2001; the Supplemental Plan did not require stockholder approval. A total of approximately 250,000 shares of common stock have been reserved for issuance under the Supplemental Plan. With limited restrictions, if shares awarded under the Supplemental Plan are forfeited, those shares will again become available for new awards under the Supplemental Plan. The Supplemental Plan permits the grant of non-statutory options and shares of restricted stock. Employees and consultants, who are not officers or members of the Board of Directors, are eligible to participate in the Supplemental Plan. Options are granted at an exercise price of not less than 85% of the fair market value per share on the date of grant. Options generally vest with respect to 25% of the shares one year after the options’ vesting commencement date and the remainder vest in equal monthly installments over the following 36 months. Options granted under the Supplemental Plan have a maximum term of ten years.
	The Compensation Committee of the Board of Directors administers the Supplemental Plan and has complete discretion to make all decisions relating to the interpretation and operation of the Supplemental Plan. The Compensation Committee has the discretion to determine which eligible persons are to receive an award, and to determine the type, number, vesting requirements and other features and conditions of each award. The exercise price of options may be paid with: cash, outstanding shares of common stock, the cashless exercise method through a designated broker, a pledge of shares to a broker or a promissory note. The purchase price for newly issued restricted shares may be paid with: cash, a promissory note or the rendering of past or future services. The Compensation Committee may reprice options and may modify, extend or assume outstanding options. The Compensation Committee may accept the cancellation of outstanding options in return for the grant of new options. The new option may have the same or a different number of shares and the same or a different exercise price. If a merger or other reorganization occurs, the agreement of merger or reorganization shall provide that outstanding options and other awards under the Supplemental Plan shall be assumed or substituted with comparable awards by the surviving corporation or its parent or subsidiary, shall be continued by the Company if it is the surviving corporation, shall have accelerated vesting and then expire early or shall be cancelled for a cash payment. If a change in control occurs, awards will become fully exercisable and fully vested if the awards do not remain outstanding, are not assumed by the surviving corporation or its parent or subsidiary and if the surviving corporation or its parent or subsidiary does not substitute its own awards that have substantially the same terms for the awards granted under the Supplemental Plan. If a change in control occurs and a plan participant is involuntarily terminated within 12 months following this change in control, then the vesting of awards held by the participant will accelerate, as if the participant provided another 12 months of service. A change in control includes: a merger or consolidation after which the then-current stockholders own less than 50% of the surviving corporation, a sale of all or substantially all of the assets, a proxy contest that results in replacement of more than one-half of the directors over a 24-month period or an acquisition of 50% or more of the outstanding stock by a person other than a person related to the Company, including a corporation owned by the stockholders. The Board of Directors may amend or terminate the Supplemental Plan at any time. The Supplemental Plan will continue in effect indefinitely unless the Board of Directors decides to terminate the plan earlier.
	In fiscal 2014, under the 2001 Long-Term Equity Incentive Plan, the Company provided issuance of stock appreciation rights to the Odessa consultants in Ukraine. To date, the Company has issued 11,350 shares under stock appreciation rights for the exercise price of $6.98. The shares will vest over four years starting from the grant date of January 21, 2014. The contractors will get 50 more shares at every anniversary of their employment. The Company reserves the right to modify this over time. The Company did not book any expense for the year ended as of March 31, 2014 as the financial impact was immaterial.
	The following table summarizes activity under the equity incentive plans for the indicated periods:
					Options and Restricted Stock Units Outstanding
		Shares			Number				Exercise			Weighted-
		Available			of				Price Per Share			Average
		for Grant			Shares							Exercise
												Price Per
												Share
		(in thousands except for per share amounts)
	Balance at March 31, 2012		1,233			476			$3.70	-	$42.40	$	7.48
	Options granted		—			—						$	—
	Options cancelled		53			(53	)					$	7.42
	Restricted stock units granted		(707	)		707						$	—
	Restricted stock units released		—			(86	)					$	—
	Restricted stock units cancelled		104			(142	)					$	—
	Balance at March 31, 2013		673			885			$3.70	-	$42.40	$	7.76
	Shares Added		187			—						$	—
	Options granted		(316	)		316						$	6.28
	Options exercised		—			(43	)					$	5.32
	Options cancelled		48			(48	)					$	11.14
	Restricted stock units granted		(530	)		530						$	—
	Restricted stock units released		—			(122	)					$	—
	Restricted stock units cancelled		493			(493	)					$	—
	Balance at March 31, 2014		555			1,025						$	6.4
Vested and expected to vest					683			$3.70	-	$34.00	$	6.44
Options outstanding and exercisable at March 31, 2014 were in the following exercise price ranges:
							Options Outstanding				Options Vested and Exercisable
Range of Exercise							Number			Weighted-	Number			Weighted-
Prices Per Share							of Shares			Average	of Shares			Average
										Remaining				Exercise Price
										Contractual				Per Share
										Life (Years)
						(in thousands except for per share amounts)
$3.70				–	$5.72		106			8.11	57		$	5.22
$6.28				–	$6.28		187			9.68	—		$	0
$6.30				–	$6.83		79			9.79	4		$	6.83
$7.20				–	$31.30		12			4.24	12		$	12.08
$34.00				–	$34.00		2			0.8	2		$	34
$3.70				–	$34.00		386			9.06	75		$	7.01
The weighted average remaining contractual term for exercisable options is 6.93 years. The intrinsic value is calculated as the difference between the market value as of March 31, 2014 and the exercise price of the shares. The market value of the Company’s common stock as of March 31, 2014 was $6.66 as reported by the NASDAQ Capital Market. There was $219,000 of aggregate intrinsic value of stock options outstanding at March 31, 2014 and there was $509,000 of aggregate intrinsic value of stock options outstanding at March 31, 2013.
The following table summarizes values for options granted during the respective years:
	Fiscal Years Ended
	March 31,
	2014			2013
	(in thousands)
Weighted average grant date fair value	$	672		$	—
Intrinsic value of options exercised	$	48		$	83
Fair value of shares vesting during the year	$	346		$	821
The following table summarizes activity for awards for the respective years:
	Shares			Grant Date				Aggregate
				Fair Value				Intrinsic
				Per Share				Value
(in thousands except for per share amounts)
Balance at March 31, 2012		246		$	5.01			$	939
Awards granted		707		$	5.51			$	—
Awards vested/released		(86	)	$	4.96			$	—
Awards cancelled/forfeited		(142	)	$	4.9			$	—
Balance at March 31, 2013		725		$	5.53			$	6,553
Awards granted		530		$	6.91			$	—
Awards vested/released		(122	)	$	6.74			$	—
Awards cancelled/forfeited		(494	)	$	5.72			$	—
Balance at March 31, 2014		639		$	6.66			$	4,255
The effect of recording stock-based compensation expense for each of the periods presented was as follows:
	Fiscal Years Ended
	March 31,
	(in thousands)
	2014			2013
Cost of revenues	$	250		$	134
Research and development		167			171
Sales and marketing		345			284
General and administrative		385			540
Impact on net loss	$	1,149		$	1,129
There were no rights granted under the employee stock purchase plan during fiscal 2013. During fiscal 2014, the fair value of rights granted under the employee stock purchase plan were estimated at the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:
	Fiscal Year Ended
	31-Mar-14
Risk-free interest rate		0.09	%
Dividend yield		0	%
Expected volatility		58.28	%
Expected term in years		0.5
Weighted average fair value at grant date	$	2.81
There were no stock options granted during fiscal 2013. During fiscal 2014, the fair value of options granted under employee stock option plans were estimated at the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:
	Fiscal Year Ended
	31-Mar-14
Risk-free interest rate		0.88	%
Dividend yield		0	%
Expected volatility		58.43	%
Expected term in years		3.21
Weighted average fair value at grant date	$	2.52
Equity Compensation Plan Information
The table below demonstrates the number of options and awards issued and the number of options and awards available for issuance, respectively, under the Company’s current equity compensation plans as of March 31, 2014:
	Number of			Weighted-				Number of
	Securities			Average				Securities
	to be			Exercise				Remaining
	Issued upon			Price Per				Available
	Exercise			Share of				for Future
	of Outstanding			Outstanding				Issuance
	Options,			Options				Under Equity
	and Rights			and Rights				Compensation
								Plans
	(in thousands, except for per share amount)
Plans Approved by Stockholders
1996 Stock Plan		1		$	31.3				147
1999 Equity Incentive Plan		838		$	6.44				224
Plans Not Required to be Approved by Stockholders
2001 Supplemental Plan		--		$	--				185
Grant to CEO Blaine Mathieu (1)		187		$	6.28				--
Total		1,025		$	6.4				556
All vested shares granted under all Plans are exercisable; however, shares exercised but not vested under the 1996 Stock Plan are subject to repurchase.
(1) Represents an option to purchase 187 thousand shares of our Common Stock granted to Mr. Mathieu outside of the 1996 and 1999 Stock Plan. The grant of this option did not require approval by our stockholders due to its qualification under the "inducement grant exception" provided by Nasdaq Listing Rule 5635(c)(4).

Note_11_Computation_of_Basic_a

Note 11 - Computation of Basic and Diluted Net Loss per Share	12 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	11.     Computation of Basic and Diluted Net Loss Per Share
	Basic and diluted net loss per share has been computed using the weighted-average number of shares of common stock outstanding during the period.
	The Company excludes potentially dilutive securities from its diluted net loss per share computation when their effect would be antidilutive to net loss per share amounts. The following common stock equivalents were excluded from the net loss per share computation:
		Fiscal Years Ended
		March 31,
		2014		2013
	Options		94		44
	Unvested restricted stock units		572		399
	Warrants		454		723
	Total common stock equivalents excluded from diluted net loss per common share		1,120		1,166

Note_12_Income_Taxes

Note 12 - Income Taxes	12 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	12.     Income Taxes
	The provision for income taxes is based upon loss before income taxes as follows:
		Fiscal Years Ended
		March 31,
		2014			2013
		(in thousands)
	Domestic pre-tax loss	$	(8,148	)	$	(4,738	)
	Foreign pre-tax loss		(31	)		(11	)
	Total pre-tax loss	$	(8,179	)	$	(4,749	)
		Fiscal Years Ended
		March 31,
		2014			2013
		(in thousands)
	Federal tax at statutory rate	$	(2,735	)	$	(1,593	)
	Computed state tax		(148	)		(255	)
	Foreign rate differential		(11	)		4
	Losses not benefited		3,089			(186	)
	Change in tax reserve		152			(161	)
	NOL expiration		—			890
	Non-deductible expenses		(275	)		(28	)
	Change in tax rate		—			1,613
	Research and development tax credits		(72	)		(274	)
	Income tax provision	$	—		$	—
	ASC 740 provides for the recognition of deferred tax assets if realization of such assets is more likely than not. Based on the weight of available evidence, which includes the Company's historical operation performance and the reported cumulative net losses in all prior years, the Company has provided a full valuation allowance against its net deferred tax assets.
	Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets are as follows (in thousands):
		March 31,
		2014			2013
		(in thousands)
	Deferred tax assets:
	Net operating loss carryforwards	$	72,646		$	68,809
	Intangible assets		11,535			12,221
	Tax credit carryforwards		5,060			5,079
	Reserves and accruals		155			225
	Depreciation		14			57
	Stock compensation		398			354
	Deferred revenue		523			472
	Total net deferred tax asset		90,331			87,217
	Valuation allowance		(90,331	)		(87,217	)
	Net deferred tax assets	$	—		$	—
	Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the net deferred tax assets have been fully offset by a valuation allowance that increased by $3.1 million and decreased by $0.1 million during 2014 and 2013 respectively.
	As of March 31, 2014 the Company had federal and state net operating loss carryforwards of approximately $198.0 million and $92.7 million respectively. As of March 31, 2014, the Company also had federal and state research and development tax credit carryforwards of approximately $3.5 million and $4.9 million, respectively.
	The federal net operating loss and credit carryforwards expire in various amounts between fiscal years ending March 31, 2019 through 2034, if not utilized. The state net operating loss carryforwards expire in various amounts between fiscal year ending March 31, 2015 through various dates, if not utilized. The state tax credit carryforwards have no expiration date.
	The Internal Revenue Code Section 382 limits the use of net operating loss and tax credit carryforwards in certain situations where changes occur in the stock ownership of a company. In the event the Company has had a change in ownership, utilization of the carryforwards could be restricted.
	Based on its most recently performed study, the Company has concluded it has not had a prior ownership change, as defined by Section 382 of the Internal Revenue Code (IRC), which could limit the future realization of its net operating loss carryforwards since June 1999. Based on this recent study, the Company believes that the application of Section 382 will not result in the forfeiture of any net operating loss carryforward for federal income tax purposes and any net operating loss carryforward for California income tax purposes. Please note the net operating loss carryforwards above take into account this belief. Applicable taxing authorities could disagree if and when an income tax return is filed that utilizes some or all of these net operating loss carryforwards.
	In addition, based on this recent study, the Company has concluded that none of the federal and California research tax credit carryforwards, respectively, would be subject to forfeiture due to Section 382 ownership changes under IRC Section 383 and/or possible credit amount reduction upon audit, but as noted above this is subject to review by the applicable taxing authority. Please note the research and development tax credit carryforwards above take into account this reduction.
	The Company is required to recognize in the financial statements the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position. The Company policy is to record interest and penalties related to unrecognized tax benefits in income tax expense. At March 31, 2014, there was no liability for unrecognized tax benefits.
	A reconciliation of the beginning and ending unrecognized tax benefit amounts for fiscal year 2014 are as follows (in thousands):
		Amount
	Balance at April 1, 2013	$	2,121
	Increases related to current year tax positions		26
	Decreases related to expiration of tax credits and statute of limitations		(38	)
	Balance at March 31, 2014	$	2,109
	The Company's federal, state and foreign tax returns are subject to examination by the tax authorities from 1999 to 2014 due to net operating loss and tax carryforwards unutilized from such years.

Note_13_401k_Benefit_Plan

Note 13 - 401(k) Benefit Plan	12 Months Ended
	Mar. 31, 2014
Compensation and Retirement Disclosure [Abstract]	'
Pension and Other Postretirement Benefits Disclosure [Text Block]	'
	13.     401(k) Benefit Plan
	The Company offers a tax-deferred savings plan, the Selectica 401(k) Plan (the 401(k) Plan), for the benefit of qualified employees. The 401(k) Plan is designed to provide employees with an accumulation of funds at retirement. Qualified employees may elect to make contributions to the 401(k) Plan on a monthly basis. Starting in fiscal 2012, the 401(k) Plan requires the Company to match the first 1% of all employee contributions. For the fiscal years ended March 31, 2014 and 2013, the Company contributed $56,000 and $42,000, respectively, to the 401(k) Plan. Administrative expenses relating to the 401(k) Plan are insignificant.

Note_14_Segment_Information

Note 14 - Segment Information	12 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Segment Reporting Disclosure [Text Block]	'
	14.     Segment Information
	The Company operates as one business segment and therefore segment information is not presented.

Note_15_Versata_Note_Payable

Note 15 - Versata Note Payable	12 Months Ended
	Mar. 31, 2014
Settlement [Abstract]	'
Settlement [Text Block]	'
	15.     Versata Note Payable
	Pursuant to the Settlement Agreement, as of March 31, 2012, the Company has paid to Versata the following payments: (i) $4.5 million for the repayment of all outstanding amounts payable under the 2007 Settlement Agreement, (ii) $472,000 for the repurchase of the Company common stock held by Versata and (iii) $500,000 for the consulting services to be provided by Versata’s affiliated entity, with an additional $500,000 payable within five business days after the one year anniversary of the Settlement Agreement.
	The Company recorded a $0 and $500,000 charge relating to the consulting services paid as part of the Settlement Agreement in both fiscal 2014 and 2013, respectively.

Note_16_Credit_Facility

Note 16 - Credit Facility	12 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Debt Disclosure [Text Block]	'
	16.     Credit Facility
	On September 29, 2011, the Company entered into a Business Financing Agreement with Bridge Bank, National Association, which was modified during fiscal 2013 (as amended, the “Credit Facility”).  The Credit Facility provides a revolving receivables financing facility in an amount up to $3.0 million (the “Receivables Financing Facility”) and a revolving cash secured financing facility in an amount up to $4.0 million (the “Working Capital Facility”), for an aggregate revolving credit facility of up to $7.0 million.
	The Receivables Financing Facility may be drawn in amounts up to $3.0 million in the aggregate, subject to a minimum borrowing base requirement equal to 80% of the Company’s eligible accounts receivable as determined under the Credit Facility. The Working Capital Facility may be drawn in such amounts as requested by the Company, not to exceed $4.0 million in the aggregate. The Credit Facility terminates on February 20, 2014, provided, however, that in the event of an early termination by the Company, a penalty of 1.0% of the total credit facility would be triggered.
	All amounts borrowed under the Credit Facility are secured by a general security interest on the assets of the Company and are subject to a 1.75 Current Ratio of (i) cash and cash equivalents plus all eligible receivables in relation to (ii) the Company’s current liabilities excluding current deferred revenue.
	Except as otherwise set forth in the Credit Facility, borrowings made under the Receivables Financing Facility will bear interest at a rate equal to the prime rate or 3.25%, whichever is greater, plus 0.25%, and borrowings made under the Working Capital Facility will bear interest at a rate equal to the financial institution’s certificate of deposit 30-day rate plus 200 basis points, with the total minimum monthly interest to be charged being $2,000.
	As of March 31, 2014 and March 31, 2013, the Company owed $6.9 million and $6.0 million, respectively, under the Credit Facility, and no amounts were available for future borrowings.

Note_17_Subsequent_Events

Note 17 - Subsequent Events	12 Months Ended
	Mar. 31, 2014
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	17.     Subsequent Events
	Entry into a Material Definitive Agreement
	On May 15, 2014, Selectica, Inc. (the “Company”) entered into a First Amendment to Lease (the “Lease Amendment”) with SKBGS I, L.L.C. amending the Office Lease dated July 8, 2011 whereby the Company is leasing approximately 10,516 square feet of office space at a premises located at 2121 South El Camino Real, Suite 1000, San Mateo, California where the Company maintains its headquarters. The Lease Amendment extends the lease term to cover a 25 month period expiring January 31, 2017 and carries a base rent of $2.85 per rentable square foot, escalating 3% each year.
	Conversion of Series D Stock
	At a special meeting of the stockholders of the Company on April 10, 2014, the stockholders approved the issuance of the shares of Common Stock, Series D Stock and 2014 Warrants issued in the 2014 Financing. Pursuant to the Company’s Certificate of Designation, Preferences and Rights of Series D Convertible Preferred Stock filed by the Company with the Delaware Secretary of State on January 23, 2014, upon such stockholder approval, each whole share of Series D Stock converted automatically into ten (10) shares of common stock at a conversion price of $6.00 per share of common stock, for a total of 690,274 conversion shares.
	Entry into an Agreement to Acquire Iasta
	On June 2, 2014, the Company entered into the Merger Agreement with Selectica Sourcing, Iasta and the Shareholders pursuant to which the Company would acquire Iasta. Subject to the terms and conditions of the Merger Agreement, to effect the Acquisition, Iasta will be merged with and into Selectica Sourcing, with Selectica Sourcing continuing as a wholly owned subsidiary of the Company.
	The aggregate purchase price for the Acquisition will be the Acquisition Shares and $7.0 million in cash (together with the Acquisition Shares, the “Purchase Price”), including amounts related to the repayment of indebtedness and payment of transaction costs. The Acquisition is not conditioned upon receipt of financing by the Company or Selectica Sourcing. The Purchase Price will be subject to certain adjustments and to a $1.4 million cash escrow (the “Escrow”) to cover any post-closing adjustments to the Purchase Price and indemnification obligations of the Shareholders. The Escrow will be deposited with Wells Fargo Bank, National Association, as escrow agent, pursuant to an Escrow Agreement to be entered into by the parties at the closing of the Acquisition. A portion of the Escrow will be released on the 12-month anniversary of the closing of the Acquisition, and the remainder of the Escrow will be released on the 18-month anniversary of the closing of the Acquisition, in each case after deducting any claims or adjustments.
	The Merger Agreement contains customary representations and warranties as well as covenants by each of the parties, including non-competition covenants made by the principal Shareholders for the benefit of the Company. Subject to certain limitations, the Company will be indemnified for damages resulting from breaches or inaccuracies by Iasta or the Shareholders of their respective representations, warranties and covenants in the Merger Agreement as well as other specified matters. The Shareholders will be indemnified by the Company for damages resulting from breaches or inaccuracies by the Company of its representations, warranties and covenants in the Merger Agreement.
	The Merger Agreement contains a “no shop” provision that, in general, prohibits Iasta from soliciting third-party acquisition proposals, provide information to or engage in discussions or negotiations with third parties that have made or might make an acquisition proposal. The Merger Agreement also contains certain termination rights by the parties.
	The Acquisition is anticipated to close during the Company’s second fiscal quarter of fiscal year 2015, subject to the satisfaction of customary closing conditions. As a condition to the closing of the Acquisition, the Company will enter into employment agreements with certain key employees of Iasta. Following the closing of the Acquisition, the Company will issue options to certain Iasta employees to purchase up to an aggregate of 700,000 shares of Common Stock of the Company, which awards will be employment inducement awards pursuant to NASDAQ Listing Rule 5635(c)(4).
	The Acquisition Shares to be issued to the Shareholders at the closing of the Acquisition have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. At the closing of the Acquisition, the Company and the Shareholders will enter into a Registration Rights Agreement with respect to registration of the resale of the Acquisition Shares.
	Entry into a Financing Agreement
	Purchase Agreement
	On June 5, 2014, the Company entered into the Purchase Agreement with the June 2014 Investors pursuant to which the Company agreed to sell, and the June 2014 Investors agreed to purchase, 124,890.5 shares of Series E Stock, at a purchase price of $60.00 per whole share (or $6.00 per one-tenth (1/10) of a share of Series E Stock, which would convert into one share of the Company’s common stock),which Series E Stock would be converted upon stockholder approval to 1,248,905 shares of Common Stock (subject to adjustment as described below). The total proceeds raised in the 2014 Second Financing would aggregate to approximately $7.5 million. The 2014 Second Financing is anticipated to close during the Company’s second fiscal quarter, subject to the satisfaction of certain closing conditions.
	Certificate of Designation for Series E Stock
	Pursuant to a Certificate of Designations, Preferences and Rights of Series E Convertible Preferred Stock to be filed by the Company with the Delaware Secretary of State (the “Certificate of Designation”) at the closing of the 2014 Second Financing, after stockholder approval, each whole share of Series E Stock would be converted automatically into ten shares of Common Stock at an initial conversion price of $6.00 per share of Common Stock, subject to broad-based weighted-average anti-dilution adjustment in the event the Company issues securities, other than certain excepted issuances and subject to certain limitations, at a price below the then current conversion price.
	The Series E Stock would not be entitled to a liquidation or dividend preference. Beginning on August 31, 2014, the Series E Stock would be entitled to 10% accruing dividends per annum. The dividends are payable quarterly in cash, beginning on September 30, 2014. Beginning on June 5, 2015, the shares of Series E Stock would be redeemed by the Company upon the request of the holders of at least a majority of the then outstanding Series E Stock, to the extent funds are legally available for such redemption. The redemption price would be equal to the product of (i) the number of shares or fraction of a share of Series E Preferred Stock to be redeemed from each such holder multiplied by (ii) ten (10) times the conversion price then in effect, plus any accrued and unpaid dividends up to, but not including, the redemption date.
	The holders of Series E Stock would have the right to vote together with the holders of the Company’s Common Stock as a single class on any matter on which the holders of Common Stock are entitled to vote, except that the holders of Series E Stock would not be eligible to vote their shares of Series E Stock on the proposal to be submitted to the Company’s stockholders for approval of the issuance and sale of the securities in the 2014 Second Financing and the conversion of the Series E Stock. Holders of Series E Stock would be entitled to cast a fraction of one vote for each share of Common Stock that would be issuable to such holder on the record date for the determination of stockholders entitled to vote at a conversion rate the numerator of which is $60.00 (as may be adjusted for any subdivision by any stock split, stock dividend, recapitalization, reorganization, scheme, arrangement or similar event occurring prior to such record date) and the denominator of which is the closing bid price per share of the Common Stock on June 5, 2014, as reported by Bloomberg Financial Markets.
	Warrants
	In addition to the issuance of the Series E Stock, at the closing of the 2014 Second Financing, the Company would issue to each June 2014 Investor a Warrant. The Warrants would be initially exercisable for an aggregate of 312,223 share of Common Stock. The exercise price of the Warrants would be $7.00 per share. The Warrants would have a five-year term, would not be exercisable for the first six months following the date of issuance and would include a cashless exercise provision which is only applicable if the Common Stock underlying the Warrants is not subject to an effective registration statement or otherwise cannot be sold without restriction pursuant to Rule 144.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	12 Months Ended
	Mar. 31, 2014
Accounting Policies, by Policy (Policies) [Line Items]	'
Consolidation, Policy [Policy Text Block]	'
	Principles of Consolidation
	The consolidated financial statements include all accounts of the Company and those of its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated.
Use of Estimates, Policy [Policy Text Block]	'
	Use of Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
Fair Value of Financial Instruments, Policy [Policy Text Block]	'
	Fair value of financial instruments
	The carrying amounts of the Company’s cash and cash equivalents, accounts receivable, accounts payable and other current liabilities approximate their fair values.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	'
	Concentrations of Credit Risk
	Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents, short-term investments, and accounts receivable. The Company places its short-term investments in high-credit quality financial institutions. The Company is exposed to credit risk in the event of default by these institutions to the extent of the amount recorded on the balance sheet. The Company’s cash balances periodically exceed the FDIC insured amounts. Investments are not protected by FDIC insurance.  Accounts receivable are derived from revenue earned from customers primarily located in the United States. The Company performs ongoing credit evaluations of its customers’ financial condition and generally does not require collateral. The Company maintains reserves for potential credit losses, and historically, such losses have not been significant.
Cash and Cash Equivalents, Policy [Policy Text Block]	'
	Cash Equivalents and Short-term Investments
	The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company’s cash equivalents consist of money market funds, certificates of deposits, and commercial paper.  Fair values of cash equivalents approximated original cost due to the short period of time to maturity. The cost of securities sold is based on the specific identification method. The Company’s investment policy limits the amount of credit exposure to any one issuer of debt securities.
	The Company monitors its investments for impairment on a quarterly basis and determines whether a decline in fair value is other-than-temporary by considering factors such as current economic and market conditions, the credit rating of the issuers, the length of time an investment has been below the Company’s carrying value, and the Company’s ability and intent to hold the investment to maturity. If a decline in fair value, caused by factors other than changes in interest rates, is determined to be other-than-temporary, an adjustment is recorded and charged to operations.
Receivables, Policy [Policy Text Block]	'
	Accounts Receivable and Allowance for Doubtful Accounts
	The Company evaluates the collectability of its accounts receivable based on a combination of factors. When the Company believes a collectability issue exists with respect to a specific receivable, the Company records an allowance to reduce that receivable to the amount that it believes to be collectible. In making the evaluations, the Company will consider the collection history with the customer, the customer’s credit rating, communications with the customer as to reasons for the delay in payment, disputes or claims filed by the customer, warranty claims, non-responsiveness of customers to collection calls, and feedback from the responsible sales contact. In addition, the Company will also consider general economic conditions, the age of the receivable and the quality of the collection efforts.
Property, Plant and Equipment, Policy [Policy Text Block]	'
	Property and Equipment
	Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method based on estimated useful lives. The estimated useful lives for computer software and equipment is three years, furniture and fixtures is five years, and leasehold improvements is the shorter of the applicable lease term or estimated useful life.
Revenue Recognition, Policy [Policy Text Block]	'
	Revenue Recognition
	The Company generates revenues by providing its SaaS solutions through subscription license arrangements and related professional services, as well as through perpetual and term licenses and related software maintenance and professional services. The Company presents revenue net of sales taxes and any similar assessments
Advertising Costs, Policy [Policy Text Block]	'
	Advertising Expense
	The cost of advertising is expensed as incurred. Advertising expense for the years ended March 31, 2014 and 2013 was approximately $209,000 and $118,000 respectively.
Research, Development, and Computer Software, Policy [Policy Text Block]	'
	Software Development Costs
	Software development costs incurred prior to the establishment of technological feasibility are included in research and development expenses. The Company defines establishment of technological feasibility as the completion of a working model. Software development costs incurred subsequent to the establishment of technological feasibility through the period of general market availability of the products are capitalized, if material, after consideration of various factors, including net realizable value.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	'
	Stock-Based Compensation
	The Company recognizes stock-based compensation expense for only those awards ultimately expected to vest on a straight-line basis over the requisite service period of the award, net of an estimated forfeiture rate. The Company estimates the fair value of stock options using a Black-Scholes valuation model, which requires the input of highly subjective assumptions, including the option’s expected term and stock price volatility. In addition, judgment is also required in estimating the number of stock-based awards that are expected to be forfeited. Forfeitures are estimated based on historical experience at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management’s judgment. As a result, if factors change and the Company uses different assumptions, its stock-based compensation expense could be materially different in the future.
Geographic Information [Policy Text Block]	'
	Geographic Information:
	International revenues are attributable to countries based on the location of the customers. For the fiscal years ended March 31, 2014 and 2013, sales to international locations were derived primarily from Canada, India, New Zealand, Switzerland and the United Kingdom.
		Fiscal Years Ended March 31,
		2014			2013
		(in thousands, except percentages)
	International Revenues		10	%		12	%
	Domestic Revenues		90	%		88	%
	Total Revenues		100	%		100	%
	For the years ended March 31, 2014 and 2013, the Company held long-lived assets outside of the United States with a net book value of approximately $67,000 and $126,000, respectively. These assets were located in Odessa, Ukraine.
Stockholders' Equity, Policy [Policy Text Block]	'
	Treasury Stock
	There were no stock repurchases other than from employees during fiscal year 2014.
	The Company had 96,000 shares of treasury stock as of March 31, 2014 and March 31, 2013.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Recent Accounting Pronouncements
	In May 2014, the FASB and the International Accounting Standards Board (IASB) issued, ASU 2014-09 (Topic 606) Revenue from Contracts with Customers. The guidance substantially converges final standards on revenue recognition between the FASB and IASB providing a framework on addressing revenue recognition issues and, upon its effective date, replaces almost all existing revenue recognition guidance, including industry-specific guidance, in current U.S. generally accepted accounting principles. The ASU is effective for annual reporting periods beginning after December 15, 2016. We are currently evaluating the impact of adopting ASU 2014-09 to determine the impact, if any, it may have on our current practices.
Customer Concentration Risk [Member]	'
Accounting Policies, by Policy (Policies) [Line Items]	'
Concentration Risk, Credit Risk, Policy [Policy Text Block]	'
	Customer Concentrations
	A limited number of customers have historically accounted for a substantial portion of the Company’s revenues. The following table presents customers that accounted for more than 10% of revenue for the last two fiscal years:
		2014			2013
	Customer A		14	%		13	%
	Customers who accounted for at least 10% of gross accounts receivable were as follows:
		Fiscal Years Ended March 31,
		2014			2013
	Customer B		29	%		22	%
	Revenue recognition criteria. The Company recognizes revenue when (1) persuasive evidence of an arrangement exists, (2) delivery has occurred or services have been rendered, (3) fees are fixed or determinable and (4) collectability is probable. If we determine that any one of the four criteria is not met, the Company will defer recognition of revenue until all the criteria are met.
	Multiple-Deliverable Arrangements. The Company enters into arrangements with multiple-deliverables that generally include subscription, support and professional services. If a deliverable has standalone value, and delivery is probable and within the Company’s control, the Company accounts for the deliverable as a separate unit of accounting. Subscription services have standalone value as such services are often sold separately, primarily through renewals. Professional services have standalone value as such services are often sold separately, and are available from other vendors.
	Upon separating the multiple-deliverables into separate units of accounting, the arrangement consideration is allocated to the identified separate units based on a relative selling price hierarchy. The Company determines the relative selling price for a deliverable based on its vendor-specific objective evidence of selling price (“VSOE”), if available, or its best estimate of selling price (“BESP”), if VSOE is not available. The Company has determined that third-party evidence of selling price (“TPE”) is not a practical alternative due to differences in its service offerings compared to other parties and the availability of relevant third-party pricing information. The amount of revenue allocated to delivered items is limited by contingent revenue, if any.
	For professional services, the Company has established VSOE as a consistent number of standalone sales of this deliverable have been priced within a reasonably narrow range. The Company has not established VSOE for its subscription services due to lack of pricing consistency, and other factors. Accordingly, the Company uses its BESP to determine the relative selling price.
	The Company determined BESP by considering its price list, as well as overall pricing objectives and market conditions. Significant pricing practices taken into consideration include the Company’s discounting practices, contract prices per user, the size and volume of the Company’s transactions, the customer demographic, and its market strategy.
	Recurring revenues. Recurring revenues consist of subscription license sales, maintenance revenues from previously sold perpetual licenses, and hosting revenues. Recurring revenues are recognized ratably over the stated contractual period.
	Non-recurring revenues.  Non-recurring revenues are comprised of revenues from professional services for system implementations, enhancements, and training, and perpetual license sales prior to fiscal 2014. For professional services arrangements billed on a time-and-materials basis, services are recognized as revenue as the services are rendered. For fixed-fee professional service arrangements, the Company recognizes revenue under the proportional performance method of accounting and estimates the proportional performance utilizing hours incurred to date as a percentage of total estimated hours to complete the project. If the Company does not have a sufficient basis to measure progress toward completion, revenue is recognized upon completion. The Company recognizes a loss for a fixed-fee professional service if the total estimated project costs exceed project revenues. Perpetual license sales are recognized upon delivery of the product, assuming all the other conditions for revenue recognition have been met.
	In certain arrangements with non-standard acceptance criteria, the Company defers the revenue until the acceptance criteria are satisfied. Reimbursements, including those related to travel and out-of-pocket expenses are included in non-recurring revenues, and an equivalent amount of reimbursable expenses is included in non-recurring cost of revenues.
	Non-recurring revenues in fiscal year 2014 were comprised of $3.6 million in professional services revenues and zero perpetual license revenues. Non-recurring revenues in fiscal year 2013 were comprised of $5.4 million in professional services and $0.4 million in perpetual license revenues.
	Customer Concentrations
	A limited number of customers have historically accounted for a substantial portion of the Company’s revenues. The following table presents customers that accounted for more than 10% of revenue for the last two fiscal years:

Note_2_Summary_of_Significant_1

Note 2 - Summary of Significant Policies (Tables)	12 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]	'
		2014			2013
	Customer A		14	%		13	%
Schedule Of Accounts Receivable By Major Customer [Table Text Block]	'
		Fiscal Years Ended March 31,
		2014			2013
	Customer B		29	%		22	%
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]	'
		Fiscal Years Ended March 31,
		2014			2013
		(in thousands, except percentages)
	International Revenues		10	%		12	%
	Domestic Revenues		90	%		88	%
	Total Revenues		100	%		100	%

Note_3_Private_Placement_Fundi1

Note 3 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Tables)	12 Months Ended
	Mar. 31, 2014
Private Placement Funding With Redeemable Convertible Preferred Stock And Warrants [Abstract]	'
Schedule of Stock by Class [Table Text Block]	'
	Gross proceeds on May 31, 2013	$	5,660
	Fair value of warrants on May 31, 2013		(2,268	)
	Gross proceeds to allocate to common stock and Series C Stock	$	3,392
	Gross proceeds allocated to common shares sold	$	2,421
	Related transaction costs allocated		(313	)
	Net value allocated to common shares sold	$	2,108
	Gross proceeds allocated to Series C Stock sold on May 31, 2013	$	971
	Related transaction costs allocated		(125	)
	Net value allocated to Series C Stock sold prior to BCF		846
	Calculated BCF value		(846	)
	Accretion of Series C Stock through September 10, 2013		1,621
	Carrying value of Series C Stock recalssified upon conversion to common stock	$	1,621
	Gross proceeds on January 24, 2014	$	8,676
	Fair value of warrants on January 24,2014		(1,789	)
	Gross proceeds to allocate to common stock and Series D Stock	$	6,887
	Gross proceeds allocated to common shares sold	$	3,646
	Related transaction costs allocated		(151	)
	Net value allocated to common shares sold	$	3,495
	Gross proceeds allocated to Series D Stock sold on January 24, 2014	$	3,241
	Related transaction costs allocated		(135	)
	Net value allocated to Series D Stock sold prior to BCF		3,106
	Calculated BCF value		(1,345	)
	Accretion of Series D Stock through March 31, 2014		1,892
	Carrying value of Series D Stock as of March 31, 2014	$	3,653

Note_4_Property_and_Equipment_

Note 4 - Property and Equipment (Tables)	12 Months Ended
	Mar. 31, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'
		March 31,
		2014			2013
		(in thousands)
	Computers and software	$	2,381		$	2,962
	Furniture and equipment		774			734
	Leasehold improvements		117			115
			3,272			3,811
	Less: accumulated depreciation		(2,960	)		(3,404	)
	Total property and equipment, net	$	312		$	407

Note_6_Accrued_and_Other_Liabi1

Note 6 - Accrued and Other Liabilities (Tables)	12 Months Ended
	Mar. 31, 2014
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]	'
Schedule of Accrued Liabilities [Table Text Block]	'
		2014		2013
		(in thousands)
	Accrued payroll and related liabilities:
	Accrued vacation	$	371	$	359
	Accrued bonus		164		287
	Accrued salaries and wages		92		86
	Accrued commissions		21		250
	Total	$	648	$	982
		2014		2013
		(in thousands)
	Deferred revenue:
	License	$	—	$	—
	Hosting		85		84
	Consulting		138		296
	Subscription		2,482		2,126
	Maintenance		2,426		3,647
	Total	$	5,131	$	6,153
		2014		2013
		(in thousands)
	Long-term deferred revenue:
	Subscription	$	168	$	766
	Maintenance		450		1,006
	Total	$	618	$	1,772

Note_10_Stockholders_Equity_Ta

Note 10 - Stockholders' Equity (Tables)	12 Months Ended
	Mar. 31, 2014
Note 10 - Stockholders' Equity (Tables) [Line Items]	'
Schedule of Common Stock Outstanding Roll Forward [Table Text Block]	'
	Equity incentive plans:
	Awards outstanding		639,000
	Options outstanding		386,000
	Reserved for future grants		555,000
	Total common stock reserved for future issuance		1,580,000
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	'
		Fiscal Years Ended
		March 31,
		(in thousands)
		2014			2013
	Cost of revenues	$	250		$	134
	Research and development		167			171
	Sales and marketing		345			284
	General and administrative		385			540
	Impact on net loss	$	1,149		$	1,129
		Fiscal Years Ended
		March 31,
		(in thousands)
		2014			2013
	Cost of revenues	$	250		$	134
	Research and development		167			171
	Sales and marketing		345			284
	General and administrative		385			540
	Impact on net loss	$	1,149		$	1,129
Schedule of Share-based Compensation, Activity [Table Text Block]	'
					Options and Restricted Stock Units Outstanding
		Shares			Number				Exercise			Weighted-
		Available			of				Price Per Share			Average
		for Grant			Shares							Exercise
												Price Per
												Share
		(in thousands except for per share amounts)
	Balance at March 31, 2012		1,233			476			$3.70	-	$42.40	$	7.48
	Options granted		—			—						$	—
	Options cancelled		53			(53	)					$	7.42
	Restricted stock units granted		(707	)		707						$	—
	Restricted stock units released		—			(86	)					$	—
	Restricted stock units cancelled		104			(142	)					$	—
	Balance at March 31, 2013		673			885			$3.70	-	$42.40	$	7.76
	Shares Added		187			—						$	—
	Options granted		(316	)		316						$	6.28
	Options exercised		—			(43	)					$	5.32
	Options cancelled		48			(48	)					$	11.14
	Restricted stock units granted		(530	)		530						$	—
	Restricted stock units released		—			(122	)					$	—
	Restricted stock units cancelled		493			(493	)					$	—
	Balance at March 31, 2014		555			1,025						$	6.4
	Vested and expected to vest					683			$3.70	-	$34.00	$	6.44
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	'
								Options Outstanding				Options Vested and Exercisable
	Range of Exercise							Number			Weighted-	Number			Weighted-
	Prices Per Share							of Shares			Average	of Shares			Average
											Remaining				Exercise Price
											Contractual				Per Share
											Life (Years)
							(in thousands except for per share amounts)
	$3.70				–	$5.72		106			8.11	57		$	5.22
	$6.28				–	$6.28		187			9.68	—		$	0
	$6.30				–	$6.83		79			9.79	4		$	6.83
	$7.20				–	$31.30		12			4.24	12		$	12.08
	$34.00				–	$34.00		2			0.8	2		$	34
	$3.70				–	$34.00		386			9.06	75		$	7.01
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
		Fiscal Years Ended
		March 31,
		2014			2013
		(in thousands)
	Weighted average grant date fair value	$	672		$	—
	Intrinsic value of options exercised	$	48		$	83
	Fair value of shares vesting during the year	$	346		$	821
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]	'
		Fiscal Year Ended
		31-Mar-14
	Risk-free interest rate		0.09	%
	Dividend yield		0	%
	Expected volatility		58.28	%
	Expected term in years		0.5
	Weighted average fair value at grant date	$	2.81
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	'
		Fiscal Year Ended
		31-Mar-14
	Risk-free interest rate		0.88	%
	Dividend yield		0	%
	Expected volatility		58.43	%
	Expected term in years		3.21
	Weighted average fair value at grant date	$	2.52
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	'
		Number of			Weighted-				Number of
		Securities			Average				Securities
		to be			Exercise				Remaining
		Issued upon			Price Per				Available
		Exercise			Share of				for Future
		of Outstanding			Outstanding				Issuance
		Options,			Options				Under Equity
		and Rights			and Rights				Compensation
									Plans
		(in thousands, except for per share amount)
	Plans Approved by Stockholders
	1996 Stock Plan		1		$	31.3				147
	1999 Equity Incentive Plan		838		$	6.44				224
	Plans Not Required to be Approved by Stockholders
	2001 Supplemental Plan		--		$	--				185
	Grant to CEO Blaine Mathieu (1)		187		$	6.28				--
	Total		1,025		$	6.4				556
Stock Awards (Member)	'
Note 10 - Stockholders' Equity (Tables) [Line Items]	'
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
		Shares			Grant Date				Aggregate
					Fair Value				Intrinsic
					Per Share				Value
	(in thousands except for per share amounts)
	Balance at March 31, 2012		246		$	5.01			$	939
	Awards granted		707		$	5.51			$	—
	Awards vested/released		(86	)	$	4.96			$	—
	Awards cancelled/forfeited		(142	)	$	4.9			$	—
	Balance at March 31, 2013		725		$	5.53			$	6,553
	Awards granted		530		$	6.91			$	—
	Awards vested/released		(122	)	$	6.74			$	—
	Awards cancelled/forfeited		(494	)	$	5.72			$	—
	Balance at March 31, 2014		639		$	6.66			$	4,255

Note_11_Computation_of_Basic_a1

Note 11 - Computation of Basic and Diluted Net Loss per Share (Tables)	12 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	'
		Fiscal Years Ended
		March 31,
		2014		2013
	Options		94		44
	Unvested restricted stock units		572		399
	Warrants		454		723
	Total common stock equivalents excluded from diluted net loss per common share		1,120		1,166

Note_12_Income_Taxes_Tables

Note 12 - Income Taxes (Tables)	12 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]	'
		Fiscal Years Ended
		March 31,
		2014			2013
		(in thousands)
	Domestic pre-tax loss	$	(8,148	)	$	(4,738	)
	Foreign pre-tax loss		(31	)		(11	)
	Total pre-tax loss	$	(8,179	)	$	(4,749	)
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	'
		Fiscal Years Ended
		March 31,
		2014			2013
		(in thousands)
	Federal tax at statutory rate	$	(2,735	)	$	(1,593	)
	Computed state tax		(148	)		(255	)
	Foreign rate differential		(11	)		4
	Losses not benefited		3,089			(186	)
	Change in tax reserve		152			(161	)
	NOL expiration		—			890
	Non-deductible expenses		(275	)		(28	)
	Change in tax rate		—			1,613
	Research and development tax credits		(72	)		(274	)
	Income tax provision	$	—		$	—
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	'
		March 31,
		2014			2013
		(in thousands)
	Deferred tax assets:
	Net operating loss carryforwards	$	72,646		$	68,809
	Intangible assets		11,535			12,221
	Tax credit carryforwards		5,060			5,079
	Reserves and accruals		155			225
	Depreciation		14			57
	Stock compensation		398			354
	Deferred revenue		523			472
	Total net deferred tax asset		90,331			87,217
	Valuation allowance		(90,331	)		(87,217	)
	Net deferred tax assets	$	—		$	—
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]	'
		Amount
	Balance at April 1, 2013	$	2,121
	Increases related to current year tax positions		26
	Decreases related to expiration of tax credits and statute of limitations		(38	)
	Balance at March 31, 2014	$	2,109

Note_2_Summary_of_Significant_2

Note 2 - Summary of Significant Policies (Details) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Note 2 - Summary of Significant Policies (Details) [Line Items]	'	'
Concentration Risk, Percentage	10.00%	'
Sales Revenue, Services, Net	$3,600,000	$5,400,000
Licenses Revenue	0	400,000
Advertising Expense	209,000	118,000
Long-Lived Assets	$67,000	$126,000
Treasury Stock, Number of Shares Held (in Shares)	96,000	96,000
Minimum [Member] | Accounts Receivable [Member]	'	'
Note 2 - Summary of Significant Policies (Details) [Line Items]	'	'
Concentration Risk, Percentage	10.00%	'

Note_2_Summary_of_Significant_3

Note 2 - Summary of Significant Policies (Details) - Major Customers by Revenues	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenue, Major Customer [Line Items]	'	'
Customer A	10.00%	'
Customer A [Member] | Customer Concentration Risk [Member]	'	'
Revenue, Major Customer [Line Items]	'	'
Customer A	14.00%	13.00%

Note_2_Summary_of_Significant_4

Note 2 - Summary of Significant Policies (Details) - Major Customers by Accounts Receivable	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Note 2 - Summary of Significant Policies (Details) - Major Customers by Accounts Receivable [Line Items]	'	'
Customer B	10.00%	'
Customer B [Member] | Credit Concentration Risk [Member]	'	'
Note 2 - Summary of Significant Policies (Details) - Major Customers by Accounts Receivable [Line Items]	'	'
Customer B	29.00%	22.00%

Note_2_Summary_of_Significant_5

Note 2 - Summary of Significant Policies (Details) - Revenues from External Customers Attributed to Foreign Countries by Geographic Area	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenues from External Customers Attributed to Foreign Countries by Geographic Area [Abstract]	'	'
International Revenues	10.00%	12.00%
Domestic Revenues	90.00%	88.00%
Total Revenues	100.00%	100.00%

Note_3_Private_Placement_Fundi2

Note 3 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) (USD $)

2 Months Ended

3 Months Ended

12 Months Ended

0 Months Ended

0 Months Ended

1 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

12 Months Ended

0 Months Ended

0 Months Ended

1 Months Ended

12 Months Ended

Mar. 31, 2014

Sep. 10, 2013

Mar. 31, 2014

Apr. 16, 2014

Mar. 31, 2013

Apr. 10, 2014

Jun. 30, 2014

Apr. 16, 2014

Jun. 30, 2014

Jun. 05, 2014

Sep. 04, 2013

Sep. 04, 2013

Sep. 12, 2013

Jan. 24, 2014

Jan. 24, 2014

31-May-13

Jan. 24, 2014

31-May-13

31-May-13

Sep. 12, 2013

Jan. 24, 2014

Jan. 24, 2014

Sep. 04, 2013

Mar. 31, 2013

Mar. 31, 2014

Sep. 10, 2013

Jan. 24, 2014

31-May-13

Sep. 10, 2013

Apr. 10, 2014

Jan. 22, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Jan. 24, 2014

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Series A Warrant (Member)

Series A Warrant (Member)

Series B Warrant (Member)

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Private Placement [Member]

Common Stock [Member]

Series C Preferred Stock [Member]

Series A Warrant (Member)

Series D Convertible Preferred Stock [Member]

Series C Convertible Preferred Stock (Member)

Series C Convertible Preferred Stock (Member)

Series D Preferred Stock [Member]

Series D Preferred Stock [Member]

Series D Preferred Stock [Member]

Series C and Series D Preferred Stock [Member]

January 2014 Financing [Member]

2013 Financing [Member]

Investors 2014 [Member]

Series D Preferred Stock [Member]

Series D Preferred Stock [Member]

Series D Preferred Stock [Member]

Private Placement [Member]

Second Closing (Member)

Common Stock [Member]

Warrant [Member]

Series C Preferred Stock [Member]

Series D Convertible Preferred Stock [Member]

Purchase Agreement (Member)

First Closing (Member)

Second Closing (Member)

January 2014 Financing [Member]

Investors 2014 [Member]

Lake Street Capital Market [Member]

Lake Street Capital Market [Member]

January 2014 Financing [Member]

Purchase Agreement (Member)

January 2014 Financing [Member]

Note 3 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

680,047

577,105

'

91,144

765,605

'

'

5,000

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Preferred Stock, Shares Issued upon Conversion

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

231,518

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sale of Stock, Price Per Share (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$7

$7

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion of Stock, Shares Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

231,518

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

'

'

'

'

'

'

'

'

'

'

404,309

'

45,571

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20,833

37,679

723,030

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)

'

'

'

'

'

'

'

'

'

'

7.75

'

7.75

'

'

'

'

'

'

'

'

7

8.75

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms

'

'

'

'

'

'

'

'

'

'

'5 years

'

'5 years

'

'5 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance or Sale of Equity (in Dollars)

'

'

$14,227,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$600,000

'

'

'

'

'

'

$3,241,000

$971,000

'

'

'

'

'

'

'

'

Share Price (in Dollars per share)

$6.66

'

$6.66

$60

'

'

'

'

$60

$60

'

'

'

$6

'

'

$60

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

1,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Redemption Amount (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,600,000

'

'

'

'

'

'

'

Initial Conversion Price of Common Stock (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$6

'

'

'

'

'

Dividends per annum, Percent

'

'

'

'

'

'

10.00%

10.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Preferred Stock, Per Share (in Dollars)

'

'

'

'

'

6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock Issued Upon Conversion

'

'

'

'

'

690,274

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

690,274

'

'

'

'

'

'

Debt Instrument, Convertible, Beneficial Conversion Feature (in Dollars)

$1,345,000

$846,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$500,000

'

'

'

Preferred Stock, Shares Issued

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

231,518

'

'

'

'

'

'

680,047

'

'

'

'

Preferred Stock, Redemption Price Per Share (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$7

'

'

'

'

'

'

'

'

'

'

'

Note_3_Private_Placement_Fundi3

Note 3 - Private Placement Funding with Redeemable Convertible Preferred Stock and Warrants (Details) - Carrying Value of the Series C Stock and Series D (USD $)

2 Months Ended

3 Months Ended

12 Months Ended

0 Months Ended

0 Months Ended

2 Months Ended

0 Months Ended

In Thousands, unless otherwise specified

Mar. 31, 2014

Sep. 10, 2013

Mar. 31, 2014

Mar. 31, 2013

Jan. 24, 2014

31-May-13

31-May-13

31-May-13

Jan. 24, 2014

31-May-13

31-May-13

Mar. 31, 2014

Jan. 24, 2014

Mar. 31, 2014

Sep. 10, 2013

Jan. 24, 2014

Jan. 24, 2014

Common Stock Series C Stock and Warrants [Member]

Common Stock and Series C Stock [Member]

Common Shares [Member]

Common Shares [Member]

Series C Convertible Preferred Stock (Member)

Series C Convertible Preferred Stock (Member)

Series D Convertible Preferred Stock [Member]

Series D Convertible Preferred Stock [Member]

Series D Convertible Preferred Stock [Member]

Common Stock Series D Stock and Warrants [Member]

Common Stock and Series D [Member]

Class of Stock [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gross proceeds

'

'

$14,227

'

'

'

$5,660

$3,392

$3,646

$2,421

$971

'

$3,241

'

'

$8,676

$6,887

Related transaction costs allocated

'

'

'

'

'

'

'

'

-151

-313

-125

'

'

-135

'

'

'

Net value allocated to common shares sold

'

'

'

-36

'

'

'

'

3,495

2,108

846

'

'

3,106

'

'

'

Calculated BCF value

-1,345

-846

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accretion of Series

1,892

1,621

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Carrying value of Series

'

'

'

'

'

'

'

'

'

'

'

3,653

'

'

1,621

'

'

Fair value of warrants on

'

'

'

'

($1,789)

($2,268)

'

'

'

'

'

'

'

'

'

'

'

Note_4_Property_and_Equipment_1

Note 4 - Property and Equipment (Details) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Property, Plant and Equipment [Abstract]	'	'
Depreciation	$158,000	$214,000

Note_4_Property_and_Equipment_2

Note 4 - Property and Equipment (Details) - Property and Equipment (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified
Property, Plant and Equipment [Line Items]	'	'
Propertly and Equipment, Gross	$3,272	$3,811
Less: accumulated depreciation	-2,960	-3,404
Total property and equipment, net	312	407
Leasehold improvements	117	115
Computer Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Propertly and Equipment, Gross	2,381	2,962
Furniture and Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Propertly and Equipment, Gross	$774	$734

Note_5_Capitalized_Software_De

Note 5 - Capitalized Software (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014
Research and Development [Abstract]	'
Finite-Lived Intangible Asset, Useful Life	'3 years
Capitalized Computer Software, Amortization	$0.01
Unamortized Balance of Capitalized Software	$0.90

Note_6_Accrued_and_Other_Liabi2

Note 6 - Accrued and Other Liabilities (Details) - Accrued Payroll and Deferred Revenue (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified
Note 6 - Accrued and Other Liabilities (Details) - Accrued Payroll and Deferred Revenue [Line Items]	'	'
Accrued vacation	$371	$359
Accrued bonus	164	287
Accrued salaries and wages	92	86
Accrued commissions	21	250
Total	648	982
Deferred revenue	5,131	6,153
Long-term deferred revenue	618	1,772
Hosting [Member]	'	'
Note 6 - Accrued and Other Liabilities (Details) - Accrued Payroll and Deferred Revenue [Line Items]	'	'
Deferred revenue	85	84
Consulting [Member]	'	'
Note 6 - Accrued and Other Liabilities (Details) - Accrued Payroll and Deferred Revenue [Line Items]	'	'
Deferred revenue	138	296
Subscription Arrangement [Member]	'	'
Note 6 - Accrued and Other Liabilities (Details) - Accrued Payroll and Deferred Revenue [Line Items]	'	'
Deferred revenue	2,482	2,126
Long-term deferred revenue	168	766
Maintenance [Member]	'	'
Note 6 - Accrued and Other Liabilities (Details) - Accrued Payroll and Deferred Revenue [Line Items]	'	'
Deferred revenue	2,426	3,647
Long-term deferred revenue	$450	$1,006

Note_7_Restructuring_Details

Note 7 - Restructuring (Details) (USD $)	3 Months Ended		9 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2013	Sep. 30, 2013	Dec. 31, 2013	Mar. 31, 2013
		Paid [Member]	Paid [Member]	Paid [Member]
Note 7 - Restructuring (Details) [Line Items]	'	'	'	'
Severance Costs	$0.30	$0.20	$0.20	$0.10

Note_8_Operating_Lease_Commitm1

Note 8 - Operating Lease Commitments (Details) (USD $)	12 Months Ended		0 Months Ended	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	15-May-14	15-May-15
			Subsequent Event [Member]	Subsequent Event [Member]
			sqft
Note 8 - Operating Lease Commitments (Details) [Line Items]	'	'	'	'
Operating Leasing Area (in Square Feet)	'	'	10,516	'
Base Operating Lease	'	'	$2.85	$2.85
Rent Escalating in Percent	'	'	3.00%	3.00%
Operating Leases, Rent Expense	200,000	200,000	'	'
Operating Leases, Future Minimum Payments Due, Next Twelve Months	200,000	'	'	'
Operating Leases, Future Minimum Payments, Due in Two Years	400,000	'	'	'
Operating Leases, Future Minimum Payments, Due in Three Years	$300,000	'	'	'

Note_9_Contingencies_Details

Note 9 - Contingencies (Details) (USD $)	0 Months Ended
In Millions, unless otherwise specified	Nov. 16, 2008	Nov. 11, 2010
Note 9 - Contingencies (Details) [Line Items]	'	'
Additional Ownership Percent Acquired	0.50%	'
Accrued Liabilities, Current (in Dollars)	'	$1
Original Ownership Threshold (Member)	'	'
Note 9 - Contingencies (Details) [Line Items]	'	'
Equity Method Investment, Ownership Percentage	15.00%	'
New Ownership Threshold (Member)	'	'
Note 9 - Contingencies (Details) [Line Items]	'	'
Equity Method Investment, Ownership Percentage	4.99%	'
Existing Percent Ownership (Member)	'	'
Note 9 - Contingencies (Details) [Line Items]	'	'
Equity Method Investment, Ownership Percentage	5.00%	'
Original Beneficial Ownership (Member)	'	'
Note 9 - Contingencies (Details) [Line Items]	'	'
Equity Method Investment, Ownership Percentage	0.51%	'
New Beneficial Ownership (Member)	'	'
Note 9 - Contingencies (Details) [Line Items]	'	'
Equity Method Investment, Ownership Percentage	6.71%	'

Note_10_Stockholders_Equity_De

Note 10 - Stockholders' Equity (Details) (USD $)

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

12 Months Ended

0 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Apr. 16, 2014

Apr. 10, 2014

Jun. 30, 2014

Apr. 16, 2014

Jun. 30, 2014

Jun. 05, 2014

Mar. 31, 2014

Nov. 07, 2012

Nov. 07, 2012

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Apr. 10, 2014

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Dec. 03, 2012

Dec. 03, 2012

Dec. 03, 2012

Mar. 31, 2014

Mar. 31, 2013

Dec. 03, 2012

Dec. 03, 2012

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Dec. 03, 2012

Dec. 03, 2012

Dec. 03, 2012

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

First Year of Employment (Member)

Originally reserved for Issuance (Member)

Amended reserved for Issuance (Member)

Per Purchase Date (Member)

Per year (Member)

Employee Stock Option [Member]

Stock Awards (Member)

Stock Appreciation Rights (SARs) [Member]

Stock Appreciation Rights (SARs) [Member]

Series D Preferred Stock [Member]

Series D Preferred Stock [Member]

Series D Preferred Stock [Member]

Incentive Stock Options (Member)

Incentive Stock Options (Member)

Non-statutory Stock Options (Member)

Non-statutory Stock Options (Member)

Employee Stock Purchase Plan (Member)

Stock Plan 1996 (Member)

Stock Plan 1996 (Member)

Plan 1999 (Member)

Plan 1999 (Member)

Long Term Performance Incentive Plan [Member]

Long Term Performance Incentive Plan [Member]

Long Term Performance Incentive Plan [Member]

Long Term Performance Incentive Plan [Member]

Long Term Performance Incentive Plan [Member]

Long Term Performance Incentive Plan [Member]

Long Term Performance Incentive Plan [Member]

Supplemental Plan 2001 (Member)

Supplemental Plan 2001 (Member)

Mr Mathieu [Member]

Chief Strategy Officer [Member]

Chief Operating Officer [Member]

Chief Commercial Officer [Member]

Series D Preferred Stock [Member]

Series D Preferred Stock [Member]

Series D Preferred Stock [Member]

Plan 1999 (Member)

Employee Stock Purchase Plan (Member)

Employee Stock Purchase Plan (Member)

Employee Stock Purchase Plan (Member)

Employee Stock Purchase Plan (Member)

Long Term Equity Incentive Plan [Member]

Long Term Equity Incentive Plan [Member]

Stock Plan 1996 (Member)

Plan 1999 (Member)

Stock Plan 1996 (Member)

Plan 1999 (Member)

Maximum [Member]

Maximum [Member]

Chief Executive Officer [Member]

Chief Financial Officer [Member]

Based Upon Achievement of Committed Monthly Recurring Revenue Targets [Member]

Vesting Once Company Achieves Profitability [Member]

Maximum [Member]

Odessa Consultants [Member]

Note 10 - Stockholders' Equity (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)

$600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition

'

'

'

'

'

'

'

'

'

'

'

'

'

'2 years 292 days

'2 years 306 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options (in Dollars)

3,100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percent of Fair Market Value

85.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100.00%

100.00%

85.00%

85.00%

'

'

'

'

'

'

'

'

'

'

'

'

85.00%

'

'

'

'

'

Allocated Share-based Compensation Expense (in Dollars)

'

1,129,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

114,000

'

'

'

'

'

'

'

100,000

400,000

'

'

'

'

'

'

'

'

Common Stock, Shares, Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,722,000

2,983,000

'

'

'

'

37,553

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share Price (in Dollars per share)

$6.66

'

$60

'

'

'

$60

$60

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Authorized

1,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Par or Stated Value Per Share (in Dollars per share)

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Issued

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

680,047

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Outstanding

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

680,047

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Dividends per annum, Percent

'

'

'

'

10.00%

10.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Preferred Stock, Per Share (in Dollars)

'

'

'

6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock Issued Upon Conversion

'

'

'

690,274

'

'

'

'

'

'

'

'

'

'

'

'

'

690,274

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Capital Shares Reserved for Future Issuance

1,580,000,000

'

'

'

'

'

'

'

'

100,000

553,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

815,000

'

1,551,000

'

'

'

'

'

'

'

'

250,000

'

187,000

'

'

'

Percent of Shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25.00%

'

25.00%

'

'

'

'

'

'

'

'

25.00%

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'4 years

'

'

'

'

'

'

'

'

'

'36 months

'10 years

'36 months

'10 years

'

'

'

'

'

'

'

'36 months

'10 years

'

'

'

'

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

'

'

'

'

'

'

'

'

66,000

'

'

5,000

10,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

33,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Award Vesting Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

40.00%

'

'

60.00%

50.00%

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

530,000

707,000

'

'

'

'

'

'

'

'

'

'

'

'

'

11,350

'

'

'

'

'

'

'

'

'

'

'

'

'

220,000

50,000

420,000

'

'

'

'

'

'

'

50,000

50,000

50,000

Percent of Employees Cash Compensation

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

15.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

85.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percent Ownership, Excluded from Plan

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right Maximum Amount Available to Purchase (in Dollars)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Appreciation Rights, Exercise Price (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$6.98

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Annual Increment in Number of Shares Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

50

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Remaining Contractual Term

'6 years 339 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value (in Dollars)

$219,000

$509,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note_10_Stockholders_Equity_De1

Note 10 - Stockholders' Equity (Details) - Common Stock Reserved for Future Issuance	Mar. 31, 2014
In Thousands, unless otherwise specified
Equity incentive plans:	'
Awards outstanding	639,000
Options outstanding	386,000
Reserved for future grants	555,000
Total common stock reserved for future issuance	1,580,000

Note_10_Stockholders_Equity_De2

Note 10 - Stockholders' Equity (Details) - Effect of Recording Stock-Based Compensation Expense (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Operating Expenses	$16,517	$14,863
Cost of Revenues (Member)	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Operating Expenses	250	134
Research and Development (Member)	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Operating Expenses	167	171
Sales and Marketing (Member)	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Operating Expenses	345	284
General and Administrative (Member)	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Operating Expenses	385	540
Impact on Net Loss (Member)	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Operating Expenses	$1,149	$1,129

Note_10_Stockholders_Equity_De3

Note 10 - Stockholders' Equity (Details) - Activity Under The Equity Incentive Plans (USD $)

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2012

Mar. 29, 2012

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2013

Mar. 29, 2012

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 29, 2012

Mar. 31, 2014

Mar. 31, 2013

Mar. 29, 2012

In Thousands, except Per Share data, unless otherwise specified

Shares Available for Grant (Member)

Shares Available for Grant (Member)

Shares Available for Grant (Member)

Shares Available for Grant (Member)

Shares Available for Grant (Member)

Shares Available for Grant (Member)

Shares Available for Grant (Member)

Shares Available for Grant (Member)

Employee Stock Option [Member]

Employee Stock Option [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Restricted Stock Units (RSUs) [Member]

Restricted Stock Units (RSUs) [Member]

Non Qualified Employee Stock Options [Member]

Note 10 - Stockholders' Equity (Details) - Activity Under The Equity Incentive Plans [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares available for grant

555,000

'

'

'

'

'

'

'

'

555

673

1,233

'

'

'

'

'

'

'

'

'

'

Number of shares

1,025

885

'

476

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Exercise Price Per Share (in Dollars per share)

$6.40

$7.76

$7.48

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$3.70

$3.70

'

$42.40

$42.40

Weighted- Average Exercise Price Per Share (in Dollars per share)

$6.40

$7.76

$7.48

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$3.70

$3.70

'

$42.40

$42.40

Vested and expected to vest

683

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Vested and expected to vest (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$3.70

'

'

$34

'

'

Vested and expected to vest (in Dollars per share)

$6.44

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares available for grant

'

'

'

'

-316

'

'

'

187

'

'

'

-316

'

'

'

'

'

'

'

'

'

Number of shares

'

'

'

'

316

'

'

'

-187

'

'

'

316

'

'

'

'

'

'

'

'

'

Weighted- Average Exercise Price Per Share (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

$6.28

'

'

'

'

'

'

'

'

'

Options exercised

'

'

'

'

'

'

'

'

'

'

'

'

-43

'

'

'

'

'

'

'

'

'

Options exercised (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

$5.32

'

'

'

'

'

'

'

'

'

Shares available for grant

'

'

'

'

48

53

'

'

'

'

'

'

48

53

'

'

'

'

'

'

'

'

Number of shares

'

'

'

'

-48

-53

'

'

'

'

'

'

-48

-53

'

'

'

'

'

'

'

'

Weighted- Average Exercise Price Per Share (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

$11.14

$7.42

'

'

'

'

'

'

'

'

Shares available for grant

'

'

'

'

'

'

-530

-707

'

'

'

'

'

'

-530

-707

'

'

'

'

'

'

Number of shares

'

'

'

'

'

'

530

707

'

'

'

'

'

'

530

707

'

'

'

'

'

'

Number of shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-122

-86

'

'

'

'

'

'

Shares available for grant

'

'

'

'

'

'

493

104

'

'

'

'

'

'

493

142

'

'

'

'

'

'

Number of shares

'

'

'

'

'

'

-493

-104

'

'

'

'

'

'

-493

-142

'

'

'

'

'

'

Shares available for grant

555,000

'

'

'

'

'

'

'

'

555

673

1,233

'

'

'

'

'

'

'

'

'

'

Number of shares

1,025

885

'

476

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Exercise Price Per Share (in Dollars per share)

$6.40

$7.76

$7.48

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$3.70

$3.70

'

$42.40

$42.40

Note_10_Stockholders_Equity_De4

Note 10 - Stockholders' Equity (Details) - Options Outstanding and Exercisable, by Exercise Range (USD $)	12 Months Ended
	Mar. 31, 2014
Range One [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Outstanding, Number of Shares (in Shares)	106
Options Outstanding, Weighted-Average Remaining Contractual Life (Years)	'8 years 40 days
Options Vested and Exercisable, Number of Shares (in Shares)	57
Options Vested and Exercisable,	$5.22
Range One [Member] | Minimum [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Prices Per Share - Minimum	$3.70
Range One [Member] | Maximum [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Prices Per Share - Maximum	$5.72
Range Two [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Outstanding, Number of Shares (in Shares)	187
Options Outstanding, Weighted-Average Remaining Contractual Life (Years)	'9 years 248 days
Options Vested and Exercisable,	$0
Range Two [Member] | Minimum [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Prices Per Share - Minimum	$6.28
Range Two [Member] | Maximum [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Prices Per Share - Maximum	$6.28
Range Three [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Outstanding, Number of Shares (in Shares)	79
Options Outstanding, Weighted-Average Remaining Contractual Life (Years)	'9 years 288 days
Options Vested and Exercisable, Number of Shares (in Shares)	4
Options Vested and Exercisable,	$6.83
Range Three [Member] | Minimum [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Prices Per Share - Minimum	$6.30
Range Three [Member] | Maximum [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Prices Per Share - Maximum	$6.83
Range Four [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Outstanding, Number of Shares (in Shares)	12
Options Outstanding, Weighted-Average Remaining Contractual Life (Years)	'4 years 87 days
Options Vested and Exercisable, Number of Shares (in Shares)	12
Options Vested and Exercisable,	$12.08
Range Four [Member] | Minimum [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Prices Per Share - Minimum	$7.20
Range Four [Member] | Maximum [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Prices Per Share - Maximum	$31.30
Range Five [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Outstanding, Number of Shares (in Shares)	2
Options Outstanding, Weighted-Average Remaining Contractual Life (Years)	'292 days
Options Vested and Exercisable, Number of Shares (in Shares)	2
Options Vested and Exercisable,	$34
Range Five [Member] | Minimum [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Prices Per Share - Minimum	$34
Range Five [Member] | Maximum [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Prices Per Share - Maximum	$34
Range Six [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Outstanding, Number of Shares (in Shares)	386
Options Outstanding, Weighted-Average Remaining Contractual Life (Years)	'9 years 21 days
Options Vested and Exercisable, Number of Shares (in Shares)	75
Options Vested and Exercisable,	$7.01
Range Six [Member] | Minimum [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Prices Per Share - Minimum	$3.70
Range Six [Member] | Maximum [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Range of Exercise Prices Per Share - Maximum	$34

Note_10_Stockholders_Equity_De5

Note 10 - Stockholders' Equity (Details) - Stock Option Activity (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Stock Option Activity [Abstract]	'	'
Weighted average grant date fair value (in Dollars per share)	$672	'
Intrinsic value of options exercised	$48	$83
Fair value of shares vesting during the year	$346	$821

Note_10_Stockholders_Equity_De6

Note 10 - Stockholders' Equity (Details) - Activity For Awards For The Respective Years (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Activity For Awards For The Respective Years [Abstract]	'	'
Shares	725	246
Grant Date Fair Value Per Share	$5.53	$5.01
Aggregate Intrinsic Value	$6,553	$939
Shares	530	707
Grant Date Fair Value Per Share	$6.91	$5.51
Shares	-122	-86
Grant Date Fair Value Per Share	$6.74	$4.96
Shares	-494	-142
Grant Date Fair Value Per Share	$5.72	$4.90
Shares	639	725
Grant Date Fair Value Per Share	$6.66	$5.53
Aggregate Intrinsic Value	$4,255	$6,553

Note_10_Stockholders_Equity_De7

Note 10 - Stockholders' Equity (Details) - ESPP Valuation Assumptions (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Note 10 - Stockholders' Equity (Details) - ESPP Valuation Assumptions [Line Items]	'	'
Weighted average fair value at grant date (in Dollars per share)	$6.91	$5.51
ESPP [Member]	'	'
Note 10 - Stockholders' Equity (Details) - ESPP Valuation Assumptions [Line Items]	'	'
Risk-free interest rate	0.09%	'
Dividend yield	0.00%	'
Expected volatility	58.28%	'
Expected term in years	'6 months	'
Weighted average fair value at grant date (in Dollars per share)	$2.81	'

Note_10_Stockholders_Equity_De8

Note 10 - Stockholders' Equity (Details) - Stock Options Valuation Assumptions (USD $)	12 Months Ended
	Mar. 31, 2014
Note 10 - Stockholders' Equity (Details) - Stock Options Valuation Assumptions [Line Items]	'
Weighted average fair value at grant date (in Dollars per share)	$672
Employee Stock Option [Member]	'
Note 10 - Stockholders' Equity (Details) - Stock Options Valuation Assumptions [Line Items]	'
Risk-free interest rate	0.88%
Dividend yield	0.00%
Expected volatility	58.43%
Expected term in years	'3 years 76 days
Weighted average fair value at grant date (in Dollars per share)	$2.52

Note_10_Stockholders_Equity_De9

Note 10 - Stockholders' Equity (Details) - Equity Compensation Plan (USD $)	12 Months Ended
	Mar. 31, 2014
Plans Approved by Stockholders	'
Number of Securities to be Issued upon Exercise of Outstanding Options, and Rights	1,025,000
Weighted- Average Exercise Price Per Share of Outstanding Options and Rights (in Dollars per share)	$6.40
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans	556
Stock Plan 1996 (Member)	'
Plans Approved by Stockholders	'
Number of Securities to be Issued upon Exercise of Outstanding Options, and Rights	1,000
Weighted- Average Exercise Price Per Share of Outstanding Options and Rights (in Dollars per share)	$31.30
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans	147
Equity Incentive Plan (Member)	'
Plans Approved by Stockholders	'
Number of Securities to be Issued upon Exercise of Outstanding Options, and Rights	838,000
Weighted- Average Exercise Price Per Share of Outstanding Options and Rights (in Dollars per share)	$6.44
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans	224
Supplemental Plan 2001 (Member)	'
Plans Approved by Stockholders	'
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans	185
Grant to CEO Blaine Mathieu [Member]	'
Plans Approved by Stockholders	'
Number of Securities to be Issued upon Exercise of Outstanding Options, and Rights	187,000	[1]
Weighted- Average Exercise Price Per Share of Outstanding Options and Rights (in Dollars per share)	$6.28	[1]
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans	'	[1]
[1]	Represents an option to purchase 187 thousand shares of our Common Stock granted to Mr. Mathieu outside of the 1996 and 1999 Stock Plan. The grant of this option did not require approval by our stockholders due to its qualification under the "inducement grant exception" provided by Nasdaq Listing Rule 5635(c)(4).

Note_11_Computation_of_Basic_a2

Note 11 - Computation of Basic and Diluted Net Loss per Share (Details) - Antidilutive Securities Excluded from the Computation of Earnings Per Share	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Total common stock equivalents excluded from diluted net loss per common share	1,120	1,166
Equity Option [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Total common stock equivalents excluded from diluted net loss per common share	94	44
Restricted Stock Units (RSUs) [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Total common stock equivalents excluded from diluted net loss per common share	572	399
Warrant [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Total common stock equivalents excluded from diluted net loss per common share	454	723

Note_12_Income_Taxes_Details

Note 12 - Income Taxes (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Note 12 - Income Taxes (Details) [Line Items]	'	'
Valuation Allowance, Deferred Tax Asset, Change in Amount	$3.10	($0.10)
Internal Revenue Service (IRS) [Member]	'	'
Note 12 - Income Taxes (Details) [Line Items]	'	'
Operating Loss Carryforwards	198	'
Deferred Tax Assets, Tax Credit Carryforwards, Research	3.5	'
State and Local Jurisdiction [Member]	'	'
Note 12 - Income Taxes (Details) [Line Items]	'	'
Operating Loss Carryforwards	92.7	'
Deferred Tax Assets, Tax Credit Carryforwards, Research	$4.90	'

Note_12_Income_Taxes_Details_L

Note 12 - Income Taxes (Details) - Loss Before Income Taxes (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Loss Before Income Taxes [Abstract]	'	'
Domestic pre-tax loss	($8,148)	($4,738)
Foreign pre-tax loss	-31	-11
Total pre-tax loss	($8,179)	($4,749)

Note_12_Income_Taxes_Details_I

Note 12 - Income Taxes (Details) - Income Tax Expense Reconciliation (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Income Tax Expense Reconciliation [Abstract]	'	'
Federal tax at statutory rate	($2,735)	($1,593)
Computed state tax	-148	-255
Foreign rate differential	-11	4
Losses not benefited	3,089	-186
Change in tax reserve	152	-161
NOL expiration	'	890
Non-deductible expenses	-275	-28
Change in tax rate	'	1,613
Research and development tax credits	($72)	($274)

Note_12_Income_Taxes_Details_D

Note 12 - Income Taxes (Details) - Deferred Income Taxes (USD $)	Mar. 31, 2014	Mar. 31, 2013
In Thousands, unless otherwise specified
Deferred Income Taxes [Abstract]	'	'
Net operating loss carryforwards	$72,646	$68,809
Intangible assets	11,535	12,221
Tax credit carryforwards	5,060	5,079
Reserves and accruals	155	225
Depreciation	14	57
Stock compensation	398	354
Deferred revenue	523	472
Total net deferred tax asset	90,331	87,217
Valuation allowance	($90,331)	($87,217)

Note_12_Income_Taxes_Details_U

Note 12 - Income Taxes (Details) - Unrecognized Tax Benefits (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014
Unrecognized Tax Benefits [Abstract]	'
Balance at April 1, 2013	$2,121
Increases related to current year tax positions	26
Decreases related to expiration of tax credits and statute of limitations	-38
Balance at March 31, 2014	$2,109

Note_13_401k_Benefit_Plan_Deta

Note 13 - 401(k) Benefit Plan (Details) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Note 13 - 401(k) Benefit Plan (Details) [Line Items]	'	'
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent	1.00%	'
401k Benefit Plan [Member]	'	'
Note 13 - 401(k) Benefit Plan (Details) [Line Items]	'	'
Defined Contribution Plan, Employer Discretionary Contribution Amount	$56,000	$42,000

Note_14_Segment_Information_De

Note 14 - Segment Information (Details)	12 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Number of Reportable Segments	1

Note_15_Versata_Note_Payable_D

Note 15 - Versata Note Payable (Details) (Versata Settlement Agreement [Member], USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Versata Settlement Agreement [Member]	'	'	'
Note 15 - Versata Note Payable (Details) [Line Items]	'	'	'
Repayments of Other Debt	'	'	$4,500,000
Payments for Repurchase of Common Stock	'	'	472,000
Professional and Contract Services Expense	$0	$500,000	$500,000

Note_16_Credit_Facility_Detail

Note 16 - Credit Facility (Details) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Note 16 - Credit Facility (Details) [Line Items]	'	'
Line of Credit Facility, Maximum Borrowing Capacity	$7,000,000	'
Line Of Credit Facility, Minimum Borrowing Base Requirement, Percentage Of Eligible Accounts Receivable	80.00%	'
Prepayment Penalty Rate	1.00%	'
Line Of Credit Facility Current Ratio Covenant	1.75	'
Line of Credit Facility, Amount Outstanding	6,949,000	6,000,000
Receivable Financing Facility [Member]	'	'
Note 16 - Credit Facility (Details) [Line Items]	'	'
Line of Credit Facility, Maximum Borrowing Capacity	3,000,000	'
Debt Instrument, Basis Spread on Variable Rate	0.25%	'
Working Capital Facility [Member]	'	'
Note 16 - Credit Facility (Details) [Line Items]	'	'
Line of Credit Facility, Maximum Borrowing Capacity	4,000,000	'
Debt Instrument, Basis Spread on Variable Rate	2.00%	'
Line Of Credit Facility Minimum Monthly Interest Charge	$2,000	'
Minimum [Member] | Receivable Financing Facility [Member]	'	'
Note 16 - Credit Facility (Details) [Line Items]	'	'
Line of Credit Facility, Interest Rate During Period	3.25%	'

Note_17_Subsequent_Events_Deta

Note 17 - Subsequent Events (Details) (USD $)

Apr. 16, 2014

Mar. 31, 2014

Jun. 05, 2014

Apr. 10, 2014

Jun. 30, 2014

Apr. 16, 2014

Jun. 05, 2014

Jun. 05, 2014

Jun. 05, 2014

Aug. 31, 2014

Jun. 05, 2014

Jun. 02, 2014

15-May-14

15-May-15

Jun. 30, 2014

Jun. 05, 2014

Apr. 10, 2014

Jan. 22, 2014

Jun. 05, 2014

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Series D Preferred Stock [Member]

Series D Preferred Stock [Member]

Series E Preferred Stock [Member]

Stock Option to be Issued to Certain Employees [Member]

Series D Preferred Stock [Member]

Series D Preferred Stock [Member]

Series D Preferred Stock [Member]

Series E Preferred Stock [Member]

Series E Preferred Stock [Member]

Series E Preferred Stock [Member]

Series E Preferred Stock [Member]

June 2014 Investors [Member]

Iasta [Member]

sqft

Iasta [Member]

June 2014 Investors [Member]

2014 Second Financing [Member]

Note 17 - Subsequent Events (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Operating Leasing Area (in Square Feet)

'

'

'

'

'

'

'

'

'

'

'

'

10,516

'

'

'

'

'

'

Base Operating Lease

'

'

'

'

'

'

'

'

'

'

'

'

$2.85

$2.85

'

'

'

'

'

Rent Escalating in Percent

'

'

'

'

'

'

'

'

'

'

'

'

3.00%

3.00%

'

'

'

'

'

Convertible Preferred Stock, Per Share

'

'

'

6

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock Issued Upon Conversion (in Shares)

'

'

'

690,274

'

'

'

'

'

'

'

'

'

'

'

'

690,274

'

'

Payments to Acquire Businesses, Gross

'

'

'

'

'

'

'

'

'

'

'

7,000,000

'

'

'

'

'

'

'

Escrow Deposit

'

'

'

'

'

'

'

'

'

'

'

1,400,000

'

'

'

'

'

'

'

Business Combination, Consideration Transferred, Equity Interests Issued and Issuable

'

'

700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues (in Shares)

'

'

'

'

'

'

124,890.50

'

'

'

'

'

'

'

'

'

'

'

'

Share Price (in Dollars per share)

$60

$6.66

'

'

'

'

'

'

'

'

'

'

'

'

$60

$60

'

'

$60

Convertible Preferred Stock Converted to Common Stock (in Shares)

'

'

'

'

'

'

'

'

1,248,905

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance of Convertible Preferred Stock

'

'

'

'

'

'

'

$7,500,000

'

'

'

'

'

'

'

'

'

'

'

Initial Conversion Price of Common Stock (in Dollars per share)

'

'

'

'

'

'

'

'

$6

'

'

'

'

'

'

'

'

$6

'

Dividends per annum, Percent

'

'

'

'

10.00%

10.00%

'

'

'

10.00%

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)

'

'

'

'

'

'

'

'

'

'

312,223

'

'

'

'

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)

'

'

'

'

'

'

'

'

'

'

7

'

'

'

'

'

'

'

'